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INTRODUCTION 
 
 Siddha system of medicine is the ancient unique and potent system among all the 
system of medicine existing at present. It was invented by Siddhars who were the 
spiritual scientists of the ancient Tamilland. Siddha system of medicine is dating up to 
5000 years.  This system maintains the physical, mental and moral health. 
 
 Siddhars had extra sensory perception, were highly spiritual and had complete 
control over all the elements.  They had full awareness of the nature and activities of all 
objects on this planet and of all times past, present and future. 
 
 The word “Siddha” means ever sure and true, ready and ever lasting derivatively. 
 
 It is a medical science through which the body as well as the soul are treated. It 
comprises of four main branches called Vatham, Maruthuvam, Yogam and Gnanam. 
The Siddha system has not only the curative and preventive effects on different diseases 
but also paves the way for longevity and immortality. 
 
 This system considers body as a whole of five elements viz, “Mann”, “Neer”, 
“Thee”, “Vali”, “Aakayam”. These are the fundamental principles of creation, 
protection and destruction of the world. The forces behind these are respectively referred 
to as Vatham, Pitham and Kapham in the case of human body. In a healthy person the 
respective ratio is 1:1/2:1/4 any imbalance in this ratio can cause disease. 
 
 Siddhars need many diagnostic tools in diagnosis of a disease.  They are the 
philosophy of “Nadi” (pulse), “Envagai thervugal (Naa, Niram, Mozhi, Vizhi, 
Malam, Moothiram, Nadi and Sparisam) Neerkuri and Neikuri. 
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 Nowaday’s people are getting too very stressed in order to keep in pace with 
modern life style. Adding fuel to the fire, the advent of fast foods, tinned foods and the 
other junk ones are giving more trouble to the gastro intestinal tract. Hence over straining 
of the gastro intestinal tract may lead to a lot of “Acid Peptic Disorders” which is 
becoming a common disease of the world. Peptic ulcer disease can be prevented by 
following the simple basic disciplines of habits and food. 
 
 There are many drugs in Siddha, which prove good against peptic ulcer disease. 
One of the Siddha medicine is “Paavana omum”  which is good medicine for the 
“Gunmam” (peptic ulcer). 
 
Madhumegam (Diabetes Mellitus) is one of the most common endocrinological 
disease. Above 40 years of age are most commonly affected by it and it is significantly 
contributing for the loss of manpower from the society from work. 
 
 In day today life for Madhumegam a lot of drugs are used in the Siddha system of 
medicine. Among them “Malaivembu Ilai Chooranam” has its beneficial results in the 
treatment of Madhumegam. The author believes that the drug has good effect on treating 
Madhumegam. 
 
 
 
 
AIM AND OBJECTIVES 
 
AIM: 
 
 To evaluate the efficacy of Malaivembu Ilai Chooranam (Melia azedarach) in 
the management of Madhumegam. 
 3
 
OBJECTIVES: 
 
 Leaves of Malaivembu (Melia azedarach) are mentioned for Madhumegam in 
“Kaikanda anuboga vaithiya perunkural42”. The disease Madhumegam found in 
Siddha texts is correlated with Diabetes Mellitus (Type II). A systemic study to access 
the efficacy of “Malaivembu Ilai Chooranam” was aimed and the main objectives of 
the study are, 
 
 To study the pharmacognostic features of the leaves of Malaivembu which includes 
taxonomic identification of the plant, macro and microscopical details of the part used 
as medicine. 
 
 To subject the Malaivembu Ilai Chooranam to thin layer chromatography to 
determine the reference values. 
 
 To study the anti-microbial activity of Malaivembu Ilai Chooranam. 
 
 To subject the Malaivembu Ilai Chooranam to biochemical analysis. 
  
 To study the acute toxicity of Malaivembu Ilai Chooranam for fixation of 
therapeutic dosage. 
 
 To study the pharmacological activity (antidiabetic) of the Malaivembu Ilai 
Chooranam. 
 
 To ascertain the clinical efficacy of the drug for the management of Madhumegam. 
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 To analyse all the above study results to evaluate the efficacy of the Malaivembu Ilai 
Chooranam. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
REVIEW OF LITERATURE 
\ÁÈºkDA (MELIA AZEDARACH.LINN) 
BOTANICAL ASPECT 
 
CLASSIFICATION:1 
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Class : Dicotyledons 
Subclass : Polypetalae 
Series : Disciflorae 
Order : Geraniales 
Family : Meliaceae 
Species : Melia azedarach 
 
VERNACULAR NAMES: 2, 3 
 
English : Persian lilac, pride of china, pride of India, Common Bead 
  tree. 
Hindi : Bakain, drek. 
Bengali : Mahanim, Ghoranim 
Marati : Pejri , Padrai 
Gujarati : Bakam limbodo 
Telungu : Turaka vepa, Kondu- vepa 
Tamil : Malaivembu 
Malayalam : Karin vembu, Sima veppu 
Kannadam : Arebevu, Hutchubevu, Chikha – bovu, Bettada – bevu 
Punjabi : Drek 
Nepal : Bakaina 
Assam : Thamaga 
Trade : Persian Lilac 
Duk : Gouri- nim 
Sanskrit : Maha – Nim, Parvata – Nimba 
 
DISTRIBUTION:2 
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 Distributed throughout India.  
 
DESCRIPTION: 
 
 A moderate sized deciduous tree, 9-12m in height with a cylindrical lobe with dark 
grey  bark having shallow longitudinal furrows. 
 
PARTS USED:  
 
Roots, leaves, seeds, flowers. 
 
LEAVES: 
 
 Bipinnate.  
 
LEAFLETS:  
 
 Ovate or lancelet, serrate, acuminate, glabrous on both surfaces, slightly oblique 
at the base, flowers lilac. 
 
PEDUNCLE: 
 
 Axillary panicles, staminal tube very conspicuous, purple, slightly ribbed out side. 
FRUITS: 
 
 Ellipsoid,  
4 seeded drupes,  
 Yellow when ripe. 
 It flowers during a hot season and fruits ripen during the cold weather. 
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CULTIVATION: 
 
 Under natural conditions, the plant regenerates freely from seeds during the rains. 
Artificial propagation is possible by direct sowing, transplanting seedlings from the 
nursery or by cuttings and root suckers. 
 
PROPERTIES AND USES: 
LEAVES:  
 
 The leaves are  
Bitter 
Astringent 
Expectorant 
Vermicidal 
Diuretic 
Emmenagogue  
Stomachic. 
They are useful in inflammation, hysteria, leprosy, scrofula, spleenomegaly, liver 
disorders, cardiac diseases, urolithiasis, strangury, amenorrhea, verminosis, cough and 
bronchitis. 
 
 
ROOTS: 
 The roots are  
Acrid 
Bitter 
Astringent 
Anodyne 
Antiseptic 
 8
Anthelmintic  
Expectorant 
Febrifuge 
Antiperiodic 
Emmenagogue  
Tonic. 
 
 They are useful in sciatica, lumbago, cephalalgia, leprosy, leucoderma, skin 
diseases, wounds, ulcers, haemorrhoids, helminthiasis, especially tapeworm, cough, 
asthma, amenorrhoea, dysmenorrhoea, diabetes and vomiting. In excessive dose, it is a 
emetic and purgative. 
 
SEEDS: 
 The seeds are  
Bitter 
Expectorant 
Anthelmintic 
Aphrodisiac.  
They are useful in helminthiasis, typhoid fever, pain in the pelvic region and 
leprosy. 
 
 
FLOWERS: 
  
 The flowers are  
Astringent 
Refrigerant 
Anodyne 
Vermifuge  
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Diuretic  
Emmenagogue. 
 
 They are useful in cephalalgia, gastropathy, dysmenorrhoea and fever. 
 
OIL: 
 
 Properties considered similar to that of neem oil. 
 Flowers and leaves are applied as poultice to relieve nervous headaches. 
 
USES: 
 
 The leaves, barks and fruits are accredited with insect repellent properties. Leaves 
are placed inside books and between folds of woollen garments to protect them against 
insect attack. 
 
 Extracts of leaves, used in sprays, protect plants against grasshoppers and locusts. 
A decoction of dry leaves is effective against locusts; the active principle is reported to be 
an alkaloid soluble in hot water. 
 
 
 
CHEMICAL CONSTITUENTS: 
 
 Kaempferol-3- L- shimano- D- glycoside m.p 181o   and rustic isolated from leaves 
4
. 
 
 Salannin and melanin also isolated 5.  Determination of kaempferol – 3 – 0 – B- D- 
rutinoside(0.14) and Quercetin -3-0- B.D- rutinoside(0.08%) in leaves. (J.Nat. Prod. 
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1986, page 49,176). Leaf extract inhibited growth of 4th instar larvae of Epilachna 
varivestis, an active principle isolated which caused 100% larval mortality at 2ppm6. Leaf 
extract from Melia azedarach inhibited phagocytes of opsonized sheep erythrocytes and 
the respiratory burst triggered by the             post-receptor stimuli, phorbol 12- myristate 
B- acetate in human monocytes7. 
 
 Bioassay of melia azedarach and Ricinus communis to assess their insecticidal 
properties against the insect. Naphthalene 2, 3, 4, 49, 5, 6- hexahydro 7-methy -1- 
(methylethyl) -6 – 01, 4 methoxd – 2 oxo-1- from methoxy -1, 2- dihydroxicotinitrite 
have been isolated from E. adenophorum8. 
 
 Water extracts of Melia azedarach at the contraction of isolated guinea pig ileum 
was tested. Water extract of Melia azedarach leaves showed a significant effect on 
enhancing the stimulatory activity of acetylcholine at doses of 16 to 128 microgram dried 
leaves/ml of bathing medium while no significant effect was observed for azadirachta 
indica9.  
 
 
 
 
 
GUNAPADAM ASPECT 
 
˛Á¶¬zD ÷¶∫Ô^ : 3 
 
 ÷Õ]BVs[ √È √VÔ∫ÔπKD, √V´ÊÔD, ∂ÿ\ˆ¬ÔV x>oB ÷¶∫ÔπKD  
√l´VzD \´D gzD. ºk©∏ÁÈl[ {´∫Ôπ_ ÔVbD ∂ÆkVF ÷D\´›m  
÷ÁÈl_ ÷´Vm. ÷>[ ÷ÁÈ ÔÚD√ﬂÁƒ W≈D. ÔVF E§m Ô™›mD,  
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cÚıÁ¶BV•D ÷Ú¬zD.  
 
√B[√|D cÆ©A:  
 
 ÷ÁÈ, ºkÏ©√‚Á¶, ∏E[.  
 
∑Ák  
 ÁÔ©A  
 
>[Á\  
 ÿk©√D  
 
∏ˆ°  
 ÔVÏ©A  
 
ÿƒFÁÔ :  
÷ÁÈ :  
 Aø¬ÿÔV_o  á  Anthelmintic  
 ÔuÆÔ·V¬˛   á  Antilithic  
 EÆ¿Ï©ÿ√Ú¬˛  á  Diuretic 
 Úm°ı¶V¬˛  á  Emmenagogue  
 ÿ√Ú\ÈD º√V¬˛  á  Cathartic  
Ø:  
 T¬Ô∫ÔÁ´ﬂE  á  Resolvent  
 Úm°ı¶V¬˛   á  Emmenagogue  
 
√‚Á¶:  
 kVÕ]•ı¶V¬˛  á  Emetic  
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zD : 12  
 "" \È‚| Aø°D klu§[ ko•D  
   ∂È‚|kVF°D º√VD ∂¶¬˛  -  ÿÔVÈ‚|D  
   cÈºkﬁ EÁ™º>kuÔı {]\º\ ºÔ·VF  
   \ÁÈºkD∏[ º√Á´ kø›m''. 
 
ÿ√Va©AÁ´ :  
 kluÆ© Aø, Û>Ô ko, ÿk§ºÂVF, c¶ÁÈ k´‚|D kπºÂVFÔ^ ¿∫zD.  
 
kw¬z :  
           1. Û>Ôko, \È‚|©Aø g˛BÁkÔÁ· ¿¬zD \ÚÕ>V˛B Ôo∫ÔV]›  
    Á>È›]_  ºƒÚ˛≈m.  
           2. ÷ÁÈﬂƒVu§_ >¬Ô ∂·° ÿÔV|›m k´, Aø¬ÔÁ·¬ ÿÔV[Æ  
               ÿkπ©√|›mD.  
           3. ∏EÁ™ >¬Ô ∂·s_ ÿÔV^·¬ ÔÚ∫Ô´©√V[, º\Ô¬Ô‚Ω,  
               ÿƒˆBV¬Ôaﬂƒ_, \ıß´_ T¬ÔD z\VzD.  
           4. √ﬂÁƒ ºkÏ©√‚Á¶ 3 √∫zD, ¿Ï 24 √∫zD ºƒÏ›m ¿Ï 1/2 √VÔD ∑ı|D  
                kÁ´ﬂ ∑Ú¬˛ √VÔD 15 -30 to T>D ÿÔV|›m kÕ>V_ kluÆ©  
    Aø¬ÔÁ·©  º√V¬zD.  
 
 
ºƒÚD \ÚÕmÔ^:  
1. WD√ √ﬁƒÔﬂ Û´D13  
 
 \ÁÈºkDA  
 ºkDA  
 Ek™VÏ ºkDA  
 Ô§ºkDA  
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 WÈºkDA   
 
 kÁÔ¬z 6 √ÈD ®|›m ÔVBÁk›m ÷Ω›m k¸]´ÔVBD ÿƒFB°D. Js´_ÿÔV^
”\·° ®|›m c‚ÿÔVı| ÿkÕ¿Ï √ÚÔ°D. 20 ÂV‚Ô^. Aπ, AÁÔlÁÈ >sÏ¬Ô°D. 
x¶¬z ÛÁÈÔ^ yÚD.  
 
2. Ôo∫ÔV]› Á>ÈD 14 
 
 kˆ¬z\‚Ωﬂ ƒVÆ  
 ÿk∫ÔVBﬂ ƒVÆ  
 ®KtﬂƒD√wﬂƒVÆ  
 \ÁÈºk©∏ÁÈﬂƒVÆ  
 Eu≈V\¬z ÿÂF  
 
÷Ák kÁÔ¬z ÔﬂƒV 1 √Ω. ÷ÁkÔÁ· ºƒÏ›m¬ ÔVFﬂE √>›]_ kΩ›m       √Úk© 
ÿ√ıÔ”¬z \V>s¶VF ÔVÈ›m 3 ÂV‚ÔπKD ÔVÁÈl_ \‚|D 1/4 ºƒÏ    ¿´VÔV´D ºƒÏ
›m¬ zΩ¬Ô Ák›m, c©∏_ÈV© √›]BD Ák¬Ô, \È‚| ºÂVFÔ^    yÚD. ÷´›> z[\D, 
\È‚|© Aø g˛B ÷ÁkÔ”D yÚD.  
 
 
 
 
MATERIALS AND METHODS 
 
SOURCE: 
 
 Material for the present study was collected from Papanaasam, Tirunelveli 
District.  
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PREPARATION OF THE MALAIVEMBU ILAI CHOORANAM: 
 
 Purified dried leaves were finely powdered in a stone motor. Then it was filtered 
by a fine white cotton cloth. 
 
PURIFICATION OF THE MALAIVEMBU ILAI CHOORANAM: 
 
 Milk and water were mixed in equal quantity and taken in a mud pot. The mouth 
of the mud pot was covered with a cloth. The pot was put on fire and burnt until milk 
mixed with water was fully evaporated. Then the prepared chooranam was allowed to 
dried by spreading. 
 
STORAGE: 
 
 The chooranam was stored in a tightly stoppered glass container and was inspected 
again to guard against the moisture and insects. As the life period of the chooranam is for 
3months only, it was used in that period. 
 
ROUTE: 
 Enteral 
 
DOSE: 
   1 gram, 2 times a day with water. 
PHARMACOGNOSTICAL STUDY  
 
METHODS FOR ANATOMICAL STUDIES: 
 
 Free hand as well as microtome sections were taken and double stained. 
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DOUBLE STAINING:  
 
 Microtome sections were stained in the following manner. Alcoholic saffranin 
(0.5%) counter stained with 0.25% fast green. This schedule gave good result for 
studying the histology of different tissues of plant organs.  All sides after staining in 
saffranin were dehydrated by employing graded series of ethyl alcohol (30%, 50%,70%, 
90% and absolute alcohol) and stained with fast green in clove oil and xylol alcohol (50-
50) and passed through xylol and mounted in DPX.  
         (Johansen, 1940) 
 
MACERATION: 
 
 Clearing of leaves for studying vein-islet number, palisade ratio, stomatal number 
and stomatal index was done by using 5% NaOH along with chlorinated soda solution 
supplemented with gentle heat. 
 
PHOTOMICROGRAPHS: 
 
 Photomicrographs were made at different magnifications, depending upon the 
anatomical details to be broughtout photomicrographs were done on the Meopta research 
microscope using Asahi pentax, 35mm SLR spotmatic 11-camera and conica colour 
film(SR 100 ASA). 
 
QUANTITATIVE MICROSCOPY: 
 
 The determination of leaf constants like stomatal number and stomatal index, 
palisade ratio, veinislet number, were carried out according to the procedures given in the 
literature and recorded in Table No 1 to 4. 
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STOMATAL NUMBER AND STOMATAL INDEX: 
STOMATAL NUMBER: 
 
 Stomatal number is the average number of stomata per sq. mm of the epidermis of 
the leaf. 
 
TABLE NO.1 
STOMATAL NUMBER: 
LOWER EPIDERMIS: 
 
Field no. No. of stomata /sq.mm 
01 70 
02 68 
03 66 
04 68 
05 70 
06 66 
 
Average stomatal number = 68/mm2 
 
 
 
STOMATAL INDEX: 
 
 Stomatal index is the percentage, which the number of stomata forms to the total 
number of epidermal cells, each stomata being counted as one cell. It is calculated by 
using the following equation. 
  S.I  = S x 100/E+S 
  S.I.  = Stomatal index 
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  S.  = Number of stomata per unit area 
  E  = Number of epidermal cells in the same area. 
 
TABLE NO. 2 
STOMATAL INDEX: 
LOWER EPIDERMIS: 
 
Field 
No 
No.of stomata per 
sq.mm(s) 
No.of Epidermal cell 
per sq.mm(E) 
Stomatal index 
I = S/E+S x 100 
01 70 36 68 
02 68 36 63 
03 68 36 63 
04 68 38 64 
05 70 36 68 
06 68 38 64 
 
       Average stomatal index = 65/mm2 
 
PROCEDURE: 
 
 Cleared the fragments of leaf from the portion between margin and midrib by 
boiling with chloral hydrate solution and prepared the mounts of lower epidermis in 
glycerin.  Drawn a square of 1mm by means of stage micrometer and camera lucida. 
Replaced the stage micrometer by the cleared leaf preparation focused under the same 
magnification and traced the epidermal cells and stomata within the square. Examined 
successive adjacent fields of about 400 cells were counted and calculated, the stomatal 
number and the stomatal index. 
 
DETERMINATION OF PALISADE RATIO: 
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 Palisade ratio is the average number of palisade cells beneath one epidermal cell 
using four contiguous epidermal cells. (fig 2D) 
 
 The leaf pieces were cleared by boiling with chloral hydrate solution and mounted 
in glycerin. The cleared preparation was focused under high magnification with the help 
of camera lucida, four contiguous epidermal cells were traced and outlined. By lowering 
the draw tube the palisade cells were focused and traced which are lying immediately 
beneath the same four- epidermal cells. 
 
TABLE NO. 3 
PALISADE RATIO: 
 
Field 
No 
No.of Epidermal 
cells per sq.mm(E) 
 
No.of palisade cells(p)
Palisade ratio 
P/E 
01 4 28 7 
02 4 32 8 
03 4 28 7 
04 4 30 7 
05 4 26 6 
06 4 28 7 
Average palisade ratio = 7 
VEIN ISLET NUMBER AND VEIN ISLET TERMINATION NUMBER: 
 
 Vein islet number is defined as the number of vein islet per sq. mm of the leaf 
surface midway between the midrib and margin. This number is independent of the side 
of the leaf and does not alter with the age of the plant. 
 
TABLE NO. 4 
VEIN ISLET NUMBER: 
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Average vein islet number = 55/mm2   
 
 
 
 
 
 
 
 
T.S. OF LEAFLET STALK: 
 
 Transverse section of leafstalk shows a small projection on the dorsal side with 
two wings on either side (fig 2A, C). The ventral side shows a huge convexity. 
 
 The epidermis is made up of single layer of cells and covered by a thick cuticle. 
Some of the epidermal cells elongate to form unicellular trichomes. In the centre, 
vasculature is represented by two superimposed bundles (fig.2C). 
Field No. Vein islet number 
per sq.mm 
01 52 
02 56 
03 58 
04 52 
05 56 
06 56 
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 On the dorsal side, the subepidermal region of the projection and wings contain 
collenchyma cells and the other region is madeup of 2-3 rows of chlorenchyma cells. On 
the lower side, the subepidermal region contain 3-4 rows of collenchyma cells (Fig.2C). 
 
 The ground tissue is made up of thin walled parenchyma cells. Most of the 
parenchyma cells that are closer to the vascular bundles contain druses of calcium oxalate 
crystals (Fig.2C). Secretory cells present in the ground tissue. 
 
T.S. OF LEAF LET: 
T.S. OF LAMINA: 
 
 Transverse section of leaflet is dorsiventral in nature (Fig.2B).  Epidermis is made 
up of single layer of cells and some of them elongate to form unicellular and rarely 
stellate trichomes. Mesophyll is differentiated into upper palisade tissue and lower 
spongy tissue (fig 2F). 
 
 Palisade tissue is single layered and made up of columnar. Closely arranged cell. It 
is followed by3-5 rows of circular to oval spongy tissue. (Fig. 2F) 
 Stomata are confined only to lower epidermis. Secretory cells are usually situated 
at the boundary between the palisade and spongy mesophyll.(Fig. 2F)  
 
T.S OF MIDRIB: 
 
 Transverse section of midrib shows a large projection on the adaxial side and 
convexity on the abaxial side. Epidermis is single layered and made up of small 
rectangular cells. The subepidermal region of the dorsal projection and abaxial side 
contain 4-5 rows of collenchyma cells. 
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 Vasculature is represented by two superimposed bundles in the centre of the 
midrib, (fig.2F). Ground tissue is made up of closely arranged round parenchyma cells. 
Secretory cells are present in the ground tissue. Most of the ground parenchyma cells 
contain druses of calcium oxalate crystals (Fig2E,I). 
 
EPIDERMIS IN SURFACE VIEW: 
 
 Adaxial foliar epidermis is made up of penta-hexagonal cells with slightly wavy 
margin stomata are absent (Fig.2G). 
 
 Abaxial foliar epidermal cell walls are wavy in nature. It is perforated by 
ranunculaceous type of stoma (Fig.2H). 
 
TRICHOMES 
 
 Clothing unicellular trichomes occur. Rarely stellate trichomes are present (Fig. 
2C). 
 
 
 
METHODOLOGY FOR THIN LAYER CHROMATOGRAPHY 
 
 2g of the sample was soaked in 20ml of rectified spirit(90%) for 18hrs, and boiled 
for 10 minutes and filtered. The filtrate was concentrated and made up to 10ml. 20µl of 
alcoholic extract was applied on Merck aluminium plate pre-coated with silica gel 60F254 
of 0.2mm thickness along with the ingredients using linomat in applicator. The plate was 
developed in Toluene: ethyl acetate; formic acid 5:2:0.5v/v. The plate was visualized in 
UV 254 and 366nm. The plate was then dipped in Vanillin-sulphuric acid and heated in 
air oven at 105o  C till the spots appeared. 
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S.No UV 254nm UV 366nm With spray reagent 
Colour Rf Colour Rf Colour Rf 
1.    -    -    -      -  Grey 0.31 
2.  - - Pink 0.36 Pale grey 0.36 
3.  - - Pink 0.47 - - 
4.  - - Brown 0.53 - - 
5.  Pale  
green 
0.56 Pink 0.58 Pale grey 0.58 
6.  Green 0.67 Pink 0.67 Grey 0.67 
7.  - - Dark pink 0.69 - - 
8.  Green 0.75 Pink 0.75 Dark grey 0.78 
9.  Green 0.83 Dark pink 0.81 Grey 0.83 
10.  - - Dark pink 0.89 - - 
11.  - - - - Pale grey 0.94 
 
 
METHODOLOGY FOR ANTI-MICROBIAL STUDY 
 
 
METHOD: 
 
 The anti-bacterial activities of different extracts of Malaivembu Ilai Chooranam 
were studied by disc diffusion method against the following organisms, 
1. Streptococcus mutans 
2. Staphylococcus aureus 
3. Escherichia coli 
4. Klebsiella pneumoniae 
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5. Pseudomonas aeruginosa. 
 
Extracts of Malaivembu Ilai Chooranam were used in the concentration of 10, 
50 and 25 µl using their respective solvents.  Ciprofloxacin (50 mcg / disc) was used as 
standard. The disc diffusion method was employed for the screening of anti-bacterial 
activity. 
 
DISC DIFFUSION METHOD. 
 
 A suspension of organism was added to sterile soya bean casein digest agar media 
at 45oC, the mixture was transferred to sterile petridishes and were allowed to solidity. 
Sterile discs, 5 mm in diameter, dipped in solutions of different extracts, standard and a 
blank was placed on the surface of agar plates.  The plates were left standing for one hour 
at room temperature as a period of preincubation diffusion to minimize the effects of 
variation in time between the application of the different solutions.  Then the plates were 
incubated at 37o C for 18 hours and observed for anti-bacterial activity.  The diameter of 
zones of inhibition were observed and measured.  The average area of zones of inhibition 
were calculated and compared with that of standard’s. 
RESULT FOR ANTI MICROBIAL STUDY OF  
MALAIVEMBU ILAI CHOORANAM  
 
Organism 
Standard 
drug 
Ciprofloxacin 
50 mcg/disc 
Test drug (Malaivembu Ilai Chooranam   
µl/disc ) 
Zone of Inhibition in mm 
10µl 25µl 50µl 
Streptococcus  
mutans  
31 15 17 21 
Staphylococcus  
aureus 
30 12 16 19 
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Escherichia coli 32 18 22 25 
Klebsiella 
pneumoniae 
29 14 21 24 
Pseudomonas 
aeruginosa 
30 16 19 22 
 
14 mm – Low sensitive, 15mm – Moderate, above 16mm – highly sensitive.  
 
 
Note :  
Sample Concentration : -  
  4gm – 400 ml of solvent in 25µl, 50µl, and 10µl/disc.  
 
Standard for Bacteria :  
  Ciprofloxacin HCL, 50 mcg/ disc. 
 
 
 
 
 
BIO CHEMICAL ANALYSIS 
 
 5gm of Malaivembu Ilai Chooranam is weighed accurately and placed in a 
250ml clean beaker and with 50ml of distilled water. Then it is boiled well for about 10 
minutes, then  it is cooled and filtered in a 100ml volumetric flastic and made upto 100ml 
with distilled water.  
 
 Then it is undergone the following tests for the presence of Acid radicals, Basic 
radicals and Phytochemical constituents in Malaivembu Ilai Chooranam.  
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QUALITATIVE ANALYSIS OF ACIDIC/BASIC RADICALS AND PHYTOCHEMICAL 
CONSTITUENTS IN MALAIVEMBU ILAI CHOORANAM 
 
Procedure Observation Inference 
Test for Calcium : 2 ml of 
extract is taken in a clean test 
tube. To this add 2 ml of  4% 
ammonium oxide solution.   
 
 White precipitate is formed Presence of calcium  
Test for Chloride : The extract 
is treated with Silver nitrate 
solution  
 
White precipitate is formed Presence of Chloride 
Test for carbonate : The 
substance is treated with Conc. 
HCl. 
Effervescence is formed  Presence of carbonate 
Test for Iron (Ferrous) : The 
extract is treated with Conc. 
HNO3 and ammonium 
thiocynate 
Blood red colour is formed Presence of Ferrous iron 
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Test for phosphate : The 
extract is treated with 
ammonium molybdate and 
conc. HNO3 
 
Yellow precipitate is formed Presence of phosphate 
Test for Tannic acid : The 
extract is treated with Ferric 
chloride  
 
Blue black precipitate is 
formed 
Presence of Tannic acid 
Test for amino acids: Dilute 
extract +2ml of Ninhydrin’s 
soln . 
 
Formation of  violet colour Presence of  amino acids 
Test for proteins: Biuret 
method ; 1ml of dilute 
extract+1mlof5%CuSO4+ 
1%NaOH. 
 
Formation of Violet   colour Presence of proteins 
Test for Flavanoids : Dilute 
extract+ mg  bits+2drops of 
conc.HCl  and gently heated. 
 
Formation of pink colour Presence of Flavanoids 
Test for phenol; Dilute 
extract+2drops of FeCl3 soln. 
 
 
 Deep green colour is formed Presence of phenols 
Test for Tannins ; dilute 
extract +2ml of 10%lead acetate 
add. 
White precipitate formed Presence of tannins 
Test for alkaloids; 
 Mayer’s method;1ml of dilute 
extract + 1ml reagent. 
 
Dragendroff’s method; 1ml of 
dilute extract+ 1ml of reagent. 
Appearance of cream colour 
precipitate 
 
 
 
Appearance of orange colour 
precipitate 
Presence of alkaloids 
 
 
 
Presence of alkaloids 
 
INFERENCE:  
 
 The Malaivembu Ilai Chooranam contains,  
Acid radicals 
   Chloride 
   Carbonate 
   Phosphate 
Basic radicals  
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   Calcium 
   Iron(Ferrous) 
Phytochemicals 
   Tannic acid  
   Amino acid 
   Protein 
   Tannins 
   Phenols 
   Flavanoids 
 
QUANTITATIVE ANALYSIS:  
Sl.No Test parameter Results 
1. Zinc 83.7mg/kg 
 
INFERENCE: The Malaivembu Ilai Chooranam sample was found to have 83.7mg/kg 
of zinc.  
ACUTE ORAL TOXICITY STUDY 
 
 
Acute oral toxicity43 was conducted as per the OECD guidelines (Organization of 
Economic Cooperation and Development) 423 (Acute Toxic Class Method). The acute 
toxic class method is a stepwise procedure with 3 animals of a single sex per step. 
Depending on the mortality and /or moribund status of the animals, on the average 2-4 
steps may be necessary to allow judgment on the acute toxicity of the test substance. This 
procedure results in the use of a minimal number of animals while allowing for 
acceptable data based scientific conclusion. 
 
The method uses defined doses (5, 50, 300, 2000 mg/kg body weight) and the 
results allow a substance to be ranked and classified according to the Globally 
Harmonized System (GHS) for the classification of chemicals which cause acute toxicity. 
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Wistar albino mice of either sex weighing 20-25 g were fasted overnight, but 
allowed water ad libitum. Malaivembu Ilai Chooranam is relatively non toxic in clinical 
practice the highest dose of 2000 mg/kg/p.o (as per OECD guidelines “Unclassified”) 
was used in the acute toxicity study.   
 
The animals were observed closely for behavioural toxicity, if any by using FOB 
(Functional observation battery). 
 
RESULT:   
 
 Malaivembu Ilai Chooranam at the doses of 2000mg/kg/po did not exhibit any 
mortality in mice. 
 
 
PHARMACOLOGICAL STUDY 
 
ANTI – DIABETIC STUDY 
 
DIABETES INDUCTION PROTOCOL 
 
Male wistar albino rats weighing between 200-250g were assigned into      3 
groups of 6 animals each.  
 Group I  - Received warm water served as solvent control  
Group II  - Received the Standard Drug (glibenclamide 2mg/kg/po) 
Group III - Received the test drug. (Malaivembu Ilai Chooranam)  
 
 Alloxan monohydrate (150mg/kg) was injected to all animals and observed for 
48hours. To avoid hypoglycemic convulsions and death rats were injected with 5% 
glucose I.P and maintained on drinking water contains 5% glucose for 48 hours. 
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 After 48 hours the blood glucose level was determined using glucometer. Animals 
showing blood glucose level < 300mg/dl were taken for the study. Animals showing 
hyperglycemic <300mg/dl were distributed to various groups. 
 
 Test drug and standard drug were given for 6days. 
 
RESULT:  
 
 At the end of 6 days animals were fasted 10hours and the fasting blood sugar was 
estimated by glucometer and reported as mg/dl. 
 
 In alloxan diabetic rats Malaivembu Ilai Chooranam at the dose of 500mg 
exhibited significant reduction is blood glucose of diabetic rats (P<0.001). The result is 
comparable to that of glibenclamide (2mg/kg/po) the standard oral hypoglycemic agent.  
 
Effect of Malaivembu Ilai Chooranam  
on Blood Glucose level in rats 
 
 
Groups Blood Glucose concentration (mg/dl) 
Control 168.56 ± 19.37 
Standard (glibenclamide 
(2mg/kg/po) 
74.16 ± 3.43*** 
Malaivembu Ilai 
Chooranam  
101.6 ± 18.98*** 
 
 
N=6; Values are expressed as mean ±S.D followed by Students Paired ‘t’ Test 
***P<0.001 as compared with that of control is considered as significant. 
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METHODOLOGY FOR STATISTICAL ANALYSIS  
 
PHARMACOLOGICAL STUDY:  
 
The statistical analysis was carried out by using one-way ANOVA (Analysis of 
variance) followed by Dunnett’s ‘t’ test. P values <0.05 were considered as significant.  
 
STATISTICAL ANALYSIS FOR CLINICAL STUDY:  
 
To find the statistical significance paired t-test was used to assess the effect of 
treatment based on symptoms. Two tailed P value was considered for statistical 
significant. Analysis was performed by using SPSS 10 (Statistical Package for social 
science) Version package. For comparison of  proportion among male and female less 
than 45 years and greater than or equal to 45 years. Chi square test was applied to find the 
statistical significance. P values less than 0.05 were considered significant.  
   t =  
d √n   
S 
d – Mean  
n – No.of Samples  
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 To study variation in one or more attributes the data are expressed mostly as 
proportions. If a sample is divided into only two classes such as successes and failures it 
is said to have a binomial. 
 
   Number of individuals having a Specific Character  
P =   
      Total Number  
   Character in a binomial distribution is expressed   
P =   
      Total Number  
  q = probability of non – occurrence of the same . 
STANDARD ERROR OF PROPORTION (S.E.P)  
 
 The probability or Proportional changes of positive or negative occurrence of an attribute 
or a character in a population or universe follows. 
 
 Binomial Frequency Distribution  
      Pq  
      N  
  
Probability of difference occurring by chance can be found by applying Z test as done in 
the case of means,   
                 p – P  
   S.E.P 
 
STATISTICAL ANALYSIS 
 
DESCRIPTIVE STATISTICS :  
 
 N Minimum Maximum Mean 
√S.E.P =  
Z =  
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Age 40 70 60 50.0 
The mean value of affected group was observed to be 50. 
 
PAIRED SAMPLES STATISTICS:  
 
Pair I 
Fasting 
Blood 
Sugar 
N Minimum Maximum Mean 
B.T  
 
40 
 
120 
 
218 
 
147 
 
A.T 40 94 110 102 
The mean Fasting blood sugar (147) before treatment was reduced to mean value 102 
after treatment.  
 
 
PAIRED SAMPLES STATISTICS:  
 
Pair I 
Post 
prandial  
blood 
sugar 
N Minimum Maximum Mean 
B.T 
 
A.T 
40 
 
40 
150 
 
110 
280 
 
140 
195.00 
 
145.00 
 
The mean Postprandial blood sugar (195.00) before treatment was reduced to mean 
145.00 after treatment.  
  
Pair  B.T vs A.T Paired Mean  t df  
Significance 
(2 tailed) 
1. Fasting blood sugar  18.9 6.250 39 0.000 
2. Postprandial blood Sugar  40.125 10.582 39 0.000 
 
Paired t-test showed significant (P<0.001) in both fasting and postprandial blood 
sugar levels after treatment at 39 degrees of freedom. The Malaivembu Ilai Chooranam 
has produced significant reduction in both fasting and postprandial blood sugar level.  
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STATISTICAL ANALYSIS OF SUBJECTIVE PARAMETERS OBSERVED 
BEFORE AND AFTER TREATMENT OF PATIENTS: 
 
S.No Parameters 
Percentage improved Statistical 
Criteria 
Probability Significance
Study  Effect Difference 
1. Poly uria  100 90 10 Z=0.66 P<0.001 Significant  
2. Polydipsia  100 85 15 Z=2.00 P<0.001 Significant  
3. Polyphagia  90 75 15 Z=1.80 P<0.001 Significant  
4. Giddiness 87.5 57.5 30 Z=1.07 P<0.001 Significant  
5. Fatigue  87 75 10 Z=1.30 P<0.001 Significant  
P <0.001 hence the improvement in the subjective parameters produced by  
Malaivembu Ilai Chooranam is statistically significant.  
CLINICAL ASSESSMENT 
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DIABETES MELLITUS 
 
It is a clinical syndrome characterized by hyperglycaemia due to absolute or 
relative deficiency of insulin. Lack of insulin affects the metabolism of carbohydrate, 
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protein and fat, and causes a significant disturbance of water and electrolyte 
homeostasis.Diabetes is world wide is distribution. 
 
AETIOLOGY: 
 
 Excessive intake of fat and high calorie food such as milk, ghee and meat, 
increased intake of alcoholic beverages, excessive carbohydrate intake, eating 
indigestible and semi cooled food, disturbance in sleeping, excessive involvement in 
sexual activities, obesity and stress. 
 
 
 
CLASSIFICATION: 
 
Two broad categories of diabetes mellitus are 
 
I. Type I (IDDM) – β cell destruction, usually leading to absolute insulin deficiency. 
 
II. Type II diabetes (NIDDM) – May range from predominantly insulin resistance 
with relative insulin deficiency to a predominantly insulin secretory defect with 
insulin resistance. 
    -  Principle of Internal medicine vol-I, 15th edition pg. 1649 – 1660 Braun wald 
 
III. Others 
1. Genetic defects 
2. Diseases of the exocrine pancreas 
3. Endocrinopathies 
4. Drug or chemical induced 
5. Infections 
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IV. Gestational diabetes mellitus. 
 
CLINICAL FEATURES :  
 
 Polyuria 
 Nocturia 
 Polydipsia 
 Polyphagia 
 Dryness of mouth 
 Rapid weight loss 
 Chronic fatigue 
 Giddiness 
 Peripheral neuritis 
 Intense itching in genitals. 
 
COMPLICATIONS OF DIABETES: 
   
1. Retinopathy 
 Impaired vision 
 
2. Nephropathy 
 Renal failure 
 
3. Peripheral neuropathy 
 Sensory loss 
 Motor weakness 
 
4. Autonomic neuropathy 
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 Postural hypotension 
 GI Problems 
 
5. Foot disease 
 Ulceration 
 Arthopathy 
 
6. Coronary circulation 
 Myocardial ischaemia / infarction 
 
 
7. Cerebral circulation 
 Transient ischaemic attack. 
 Stroke 
 
8. Peripheral circulation 
 Claudication 
 Ischaemia 
 
DIAGNOSTIC CRITERIA 
BLOOD GLUCOSE 
 
Fasting 
 
 Normal <110mg/dl 
 Borderline >110 but less than 125mg% 
 Diabetes mellitus >126mg% 
 
Postprandial 
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 Normal <140mg/dl 
 Borderline >140but less than 200mg% 
 Diabetes mellitus> 200mg % 
 
Medical advice: 
 
1. The diet should include complex carbohydrates, protein decreased fat and low 
calories.  
 
2. Advised to take small frequent meals. 
 
3. Advised to avoid / sweety, excessive salty, sour tastes in food. 
 
4. Advised to take food rich in fibre content (20-30gm per day). 
 
5. Advised to monitor blood  glucose levels regularly.  
 
6. Advise to do aasanas and pranayamam. 
 
7. Advised to do moderate exercise and brisk walk (2-3km /day). 
 
A Clinical trial on Madhumegam was carried out in Govt.Siddha Medical 
College, Arignar Anna Indian Medicine Hospital, Arumbakkam, Chennai – 106. 40 
Cases with clinical signs and symptoms of Madhumegam of both sexes of age group 
above 30yrs were selected and studied under the guidance of Professor, Reader and 
Lecturers, Assistant Lecturers of PG II Department. All the cases were carried out in the 
OP.  
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 The Parameters for the case selection were  
(i) Polyuria, 
(ii) Polydipsia  
(iii) Polyphagia 
(iv) Giddiness 
(v) Fatigue  
(vi) Peripheral neuritis.  
 
Age Group : 30 – 70 years of both sexes.  
 
 
The following routine laboratory investigations were done :  
 
Urine Analysis  
(i) Albumin  
(ii) Sugar  
(iii) Deposits  
 
Biochemical Analysis  
 
 Blood sugar (Fasting or Postprandial) were carried out before treatment and after 
treatment.  
 
EXCLUSION CRITERIA  
 
 Patients with type I diabetes mellitus  
 Pregnancy induced diabetes mellitus  
 Patient with renal impairment  
 Patient with hypertension  
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 Patient with other cardiovascular problems, pancreatic pathology and liver 
afflictions.  
 Patients with diabetic nephropathy and retinopathy.  
 
WITHDRAWAL CRITERIA  
 
 Irregular medication  
 Patients who followed dual treatment.  
 
 
 
INCLUSION CRITERIA  
 
 Patients of age group above 30-70 years.  
 Patients of either sex.  
 Patients suffering from non-insulin dependent Diabetes mellitus (NIDDM) type II.  
 Non – Obese  
 Clinical Parameters- Polyuria, Polydipsia, Fatigue , Giddiness, Peripheral neuritis.   
 Investigative parameters 
1 Fasting blood sugar of 110mg /dl and above  
2 Postprandial blood sugar of 140mg/dl and above.  
 
LINE OF TREATMENT  
 
1g of Malaivembu Ilai Chooranam was administered with water before food, 
twice daily for a period of 48 days.  
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 The patients were advised to visit follow-up once in 7 days for a general 
observation related to dose adaptations and parallel clinical parameters were recorded. 
The efficacy follow-up was taken up at the end of 48 days of therapy.  
 
 
 
 
 
 
 
 
DIET CHART :  
 
Vegetarian Non-vegetarian 
Bed tea or Coffee without sugar 1 cup  Bed tea or Coffee without sugar 1 cup 
Breakfast :  
    Toast 2 Oz or Atta 60gm  
    Channa – 50 gm  
    Boiled vegetables  - 100gm 
    Tea without sugar 1 cup 
     Milk (Skimmed) – 1 cup  
Breakfast :  
     Toast 2 Oz% or Atta – 60gm  
     Egg – 1  
     Tea without sugar 1 cup  
Mid–morning : 
   Sugarless biscuits – 2 
    Milk (Skimmed) – 1 Cup  
Mid–morning : 
   Sugarless biscuits – 2 
    Milk (Skimmed) – 1 Cup 
Lunch : 
    Rice or Atta – 70gm  
    Dal – 1 cup 
    Channa Curry – 100gm  
    Green Vegetables – 250gm  
Lunch : 
   Rice or Atta – 70gm  
   Dal – 1 cup  
   Fish/meat – 100gm  
   Buttermilk 1 cup  
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     Buttermilk  - 1 cup  
Evening:  
   Sugarless biscuits -2  
   Tea without sugar – 1 cup  
Evening:  
   Sugarless biscuits -2  
   Tea without sugar – 1 cup 
Dinner : 
     Atta – 70gm  
     Green Vegetables – 250gm  
     Channa Curry 50gm  
Dinner:  
     Atta – 70 gm  
     Green Vegetables – 250gm  
     Fish / Meat 100gm  
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S.No Op.No Patient Name Age Duration of Treatment 
Before Treatment After Treatment 
Blood Sugar 
(mg%) 
 
Urine 
Sugar 
 
Blood Sugar (mg%) Urine 
Sugar 
F PP F PP 
1. 5128 Jeganathan 60 11.09.07 – 20.10.07 136 170 + 95 115 Nil 
2. 5317 Uma  50 12.09.07 – 20.10.07 181 200 ++ 109 120 Nil 
3. 1171 Indhra  45 24.10.07 – 30.11.07 136 160 Nil 100 120 Nil 
4. 1721 Sangeetha 53 26.10.07 – 06.12.07 148 170 + 106 125 Nil 
5. 3795 Kamala  52 03.11.07 – 17.12.07 159 170 ++ 100 130 Nil 
6. 4089 Malliga  50 04.11.07 – 17.12.07 161 180 + 105 135 Nil 
7. 4660 Bharath  52 06.11.07 – 18.12.07 138 150 + 98 110 Nil 
8. 4527 Anna Poorani 46 06.11.07 – 18.12.07 138 150 + 100 115 Nil 
9. 4621 Leelavathi  49 06.11.07 – 18.12.07 146 160 + 105 110 Nil 
10. 9726 Rajamani 48 22.11.07 – 31.12.07 130 192 Nil 105 140 Nil 
11. 9734 Lalitha  50 22.11.07 – 31.12.07 141 170 + 96 110 Nil 
12. 1620 Sujatha  34 27.11.07 – 31.12.07 159 280 ++ 102 130 Nil 
13. 1572 Gandhimadhi 43 27.11.07 – 31.12.07 130 198 Nil 100 120 Nil 
14. 16584 Akli 45 27.11.07 – 31.12.07 200 259 ++ 100 120 Nil 
15. 5092 Syed Unksen 48 07.12.07 – 28.01.08 158 170 Nil 94 130 Nil 
16. 5956 Thangappan 47 10.12.07 – 12.01.08 140 160 Nil 100 130 Nil 
17. 169 Valliammai 67 22.12.07 – 08.02.08 142 200 Nil 100 120 Nil 
18. 4893 Nataraj 65 09.01.08 – 17.03.08 218 250 ++ 108 130 Nil 
19. 8506 Selvarangam 66 18.01.08 – 10.03.08 183 210 Nil 105 125  Nil 
20. 9935 Sumathi 36 22.01.08 – 10.03.08 148 200 Nil 107 135 Nil 
21. 436 Sasikala 42 23.01.08 – 10.03.08 185 200 Nil 102 125 Nil 
22. 781 Lakshman  62 24.01.08 -10.03.08 198 210 + 100 135 Nil 
23. 1954 Durai 70 28.01.08 – 17.03.08 151 202 + 105 120 Nil 
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24. 2568 Ravi 45 29.01.08 – 17.03.08 124 150 Nil 96 136 Nil 
25. 2490 Karunanidhi  40 29.01.08 – 17.03.08 120 158 Nil 110 132 Nil 
26. 2581 Govindaswamy  65 29.01.08 – 17.03.08 160 260 +++ 108 130 Nil 
27. 2541 Rajarathinam 70 29.01.08 – 17.03.08 141 191 Nil 109 120 Nil 
28. 4079 Roobalingam 59 02.02.08 -17.03.08 198 220 + 110 126 Nil 
29. 4594 Subbaiya  70 04.02.08 -17.03.08 150 200 Nil 98 130 Nil 
30. 5279 Dhinakaran 47 05.02.08 -28.03.08 170 270 ++ 109 137 Nil 
31. 5295 Eswari 38 05.02.08 – 28.03.08 130 180 Nil 110 133 Nil 
32. 5315 Selvaraj Kumar 59 05.02.08 – 28.03.08 128 200 Nil 98 130 Nil 
33. 6007 Hemachandran 55 07.02.08 -20.03.08 130 210 Nil 105 120 Nil 
34. 7284 Thomas  70 08.03.08 – 21.04.08 160 240 + 100 140 Nil 
35. 6729 Chandra 53 08.03.08 – 21.04.08 156 260 Nil 106 138 Nil 
36 9986 Ezhumalai 55 10.03.08  - 21.04.08 139 170 Nil 100 136 Nil 
37. 8488 Parimala  56 11.03.08 – 21.04.08 143 160 Nil 102 130 Nil 
38. 8397 Ramaswamy 55 11.03.08 – 21.04.08 139 160 Nil 98 136 Nil 
39. 8333 Lalitha  54 11.03.08 – 21.04.08 136 150 + 96 126 Nil 
40. 8399 Ramaswamy 56 11.03.08 -21.04.08 163 200 Nil 98 130 Nil 
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AGE DISTRIBUTION
30%
25%
32.50%
12.50%
31-40 41-50 51-60 61-70
AGE DISTRIBUTION:  
 
  
S.No Age in Years No.of Patients Percentage  (%)
1. 31-40 12 30 
2. 41-50 10 25 
3. 51-60 13 32.5 
4. 61-70 5 12.5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INFERENCE :  
 Among 40 Patients. 12 (30%) belong to age group 31-40, 10 (25%) patients 
belong to age group 41-50, 13 (32.5%) patients belong to age group 51-60 and 5 (12.5%) 
patients belong to age group 61-70. Maximum patients found to be between 51-60. 
 
 
 
SEX DISTRIBUTION:  
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S.No Sex No.of.Cases Percentage  (%) 
1. Male  23 57.5 
2. Female  17 42.5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INFERENCE  
 Out of 40 Patients 23 cases(57.5%) were male and 17 cases (42.5%) were female.  
 
 
 
 
 
 
SOCIO- ECONOMIC STATUS:  
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S.No Socio – Economic Status  No.of.Cases Percentage  (%) 
1. Poor  29 72.5 
2. Middle 6 15.0 
3. Rich  5 12.5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INFERENCE :  
Among 40 patients 29(72.5%) were poor, 6(15%) were middle class and 5 
(12.5%) were rich.  
 
 
 
HABIT WISE DISTRIBUTION : 
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SOCIO- ECONOMIC STATUS
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S.No Habit and Diets  No.of.Cases Percentage  (%) 
1. Vegetarian  6 15 
2. Mixed diet 34 85 
3. Smoking  12 30 
4. Alcohol  7 17.5 
 
 
 
 
 
INFERE
NCE :  
 T
his table 
shows 
that food 
habit do 
not show any influence in case of Madhumegam. Among 40 patients. 6(15%) were 
vegetarian, 34(85%) were mixed diet, 12(30%) were smoker 7(12.5%) were alcoholic.  
 
 
OCCUPATION WISE DISTRIBUTION: 
 
S.No Occupation  No.of.Cases Percentage  (%) 
1. House wife 24 60 
2. Retired person  10 25 
3. Business men  5 12.5 
4. Police man  1 2.5 
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15 17.5
85
30
0
20
40
60
80
100
Vegetarian Mixed diet Smoking Alcohol 
Habit and Diet 
Pe
rc
en
ta
ge
 
 50
OCCUPATION WISE DISTRIBUTION
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Inference:  
 Among 40 patients 24(60%) patients were housewives, 10 (25%) patients was 
retired person, 5(12.5%) patients were business men and 1 (2.5%) were  police man.  
 
SYMPTOM WISE DISTRIBUTION 
 
Symptoms Before 
Treatment 
After 
Treatment 
Improvement Percentage 
(%)  
Polyuria 40 4 36 90 
Polydipsia 40 6 34 85 
Polyphagia 36 6 30 75 
Giddiness 35 12 23 57.5 
Fatigue 34 4 30 75 
Peripheral neuritis 25 14 11 27.5 
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INFERENCE:  
 Patients with the symptoms  that is Polyuria, Polydipsia, Polyphagia, Giddiness, 
Fatigue, Peripheral Neuritis were taken for the study. Among 40 patients with polyuria 36 
patients improved from polyuria. Among 40 patients with polydipsia 34 improved. 
Among 36 patients with polyphagia 30 patients improved. Among 35 patients with 
giddiness 23 got relief. Among 34 patients with fatigue 30 got improvement. Among 25 
patients with peripheral neuritis only 11 got improvement.  
GRADATION OF RESULTS :  
 
S.No Grade No.of.Cases Percentage  (%) 
1. Good 30 75 
2. Moderate  5 12.5 
3. Poor 5 12.5 
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GRADATION OF RESULTS 
12.50%
12.50%
75%
Good Moderate Poor
 
 
 
INFERENCE :  
 Among the 40 cases, 75% of cases show good results, 12.5% of cases show 
moderate results and 12.5% of case show poor results.    
 
 
 
DISCUSSION 
 
 To day’s fast moving life style with its unhealthy food habits and increased stress 
are taking its role on human health and among the disease caused due to the occurrence 
of Madhumegam  is increasing at an alarming rate. 
 
As per Siddha system, Madhumegam is caused by derangement of pittham. 
""√ÔÏ∏›> sÕÁ>BÈVm º\ÔD k´Vm''  
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   - E›> \Ú›mk ºÂVF ÂV¶_ ºÂVF x>_ ÂV¶_  
 
  "" Ô[M \B¬Ô›>V_ ÔıΩ|D º\Ôº\''  
       - ÂVΩ ±_, ]ÚJÈÏ 
>[sÁ™, ∏≈sÁ™Ôπ[ ∂·kVÔ ∏›>D >[MÁÈl_ ºÔ¶Á¶Õm 
ˇμ   ºÂV¬z¬ÔV_,   º\_   ºÂV¬z¬ÔV_,  √´°ÔV_    ∂›m¶[   ºÔ¶Á¶Õm   
c¶uÔ‚|Ô^ ∞aÁ™•D Œ[≈[ ∏[ Œ[≈VÔ ºÔ¶Á¶Bﬂ ÿƒFm ÂV·Á¶s_  
√E›yÁB¬ ÿÔ|¬zD. ®™ºk ºÔ¶Á¶Õ> x¬zu≈∫ÔÁ·•D, ÔV_Ôπ[  
ÿÔ|]ÁB•D ƒˆÿƒFB ºkı|D.  
 ÁÔ©A, mkÏ©Aﬂ∑ÁkÔ·V™m ∏›>tz]ÁB ƒ\™©√|›mD. \ÁÈ ºkDA  
ÁÔ©Aﬂ∑Ák•Á¶B JoÁÔ gzD.  
 "" ∏›>\] Ôˆ©∏[ º√∑D √ˆÔV´D 
   ∑›>› mkÿ´V| ÿƒV_oM©Aﬂ á ƒ›>VzD 
   ÁÔ©Aﬂ ∑ÁkºB ÔÚ>k>[ TÆ  
    ®F©AÁ¶• ÿ\[ÆÁ´› >Vˆ∫z''  
   á ºÂVF ÂV¶_ ºÂVF x>_ ÂV¶_  
\ÁÈºkDA ∏›>tz]ÁB ƒ\™©√|›], \mº\Ô ºÂVlÁ™ Ô‚|©√V‚Ωuz^  
Ák¬zD.  
 ÁÔ©A ∑ÁkBV™m kV• \uÆD gÔVB Ø>¬ ÌÆÔ^ ºƒÏÕ>m.  
º\Ôs´›Á> z\V¬zD >[Á\ kV• Ø>›]uz c^·m.  
 The antimicrobial study of Malaivembu Ilai Chooranam shows that it is highly 
sensitive to all the following organisms such as,  
 
Streptococcus mutans 
Staphylococcus aureus 
Escherichia coli 
Klebsiella pneumoniae 
Pseudomonas aeruginosa. 
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 Daily requirement of Zinc26 is 0.3 mg/kg/per day. 
 
 Zinc present in cereals, pulses, nuts and oil seeds are poorly absorbed dueto the 
presence of phytic acid which interferes in its absorption. 
 
 Zinc41 maintains normal concentration of Vitamin A in plasma.  It is required for 
the mobilization of Vitamin A from the liver. 
 
 Zinc is required for the preparation of insulin and increases and the duration of 
insulin action, when given by injection. Zinc is used in the β cells of the pancreas 
to store and release insulin in required. 
 
 Helps in the formation of Zinc hexamers which helps in storage and subsequent 
release at insulin – Ref. Research abstract – Ayur Medline 2000 may. 
 
 Zinc is concerned with the healing of wounds which is common problem in 
Madhumegam. 
 
 Zinc is essential for the normal growth and reproduction of animals. 
 
 Malaivembu Ilai Chooranam has Zinc 83.7mg/kg. So Malaivembu Ilai 
Chooranam controls the Madhumegam because of zinc which is in the       β 
cells of the pancreas to store and release insulin as required. 
 
 In Madhumegam reduction of body weight, suppression of immune system 
occurs and nervous tissue also gets affected. 
 
                          "" º\Ô∫ ˛·Ïº√] ÿk‚Á¶BwÁÈ› >Ë¬zD  
   ºkÔ∫ ˛´VË sÈ¬z∫ÔVı á º√VÔV©  
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   √ˆBxÁ· AıÁ© √l›]B›Á>© º√V¬zD   
   ∂ˆBm›> ÂVÔ \m ''   
   - z√V¶D >Vm kz©A  
 
ÿ√Va©AÁ´ :  
º\ÔD, º√], ÿk^Á·, c‚Û|, ˛´ÔË, xÁ·©Aı, ∏›>D x>oB ºÂVF
ÔÁ· ¿¬zD.  
 
             "" ÿƒV_o xΩBVm m›>ÂV ÔDÿ√VΩBVF  
   ÿ\_È› m´›mD sBV]ÔÁ· á Â_È  
   c´–Á¶Á\ •ı¶V¬zD cı¶kÁ´ ÿB[Æ 
   ˛Út \Á™ \ı\˛Á\ ºÔ^''  
   - z√V¶D >Vm kz©A  
 
ÿ√Va©AÁ´ :  
ºÂVl™V_ ÿ\oÕm º√V™ ƒZ´›Á> ÔV©√Vu§ Â[Á\ÁB› >ÚD.  
º\uÔı¶ √V¶_Ôπ[ kVlÈVÔ m›>ÂVÔ\V™m \mº\Ô  
ºÂVlÁ™•D, ∂Á> ÿ>V¶ÏÕm kÚD c¶_ ÿ\okÁ¶>ÁÈ•D 
√ˆÔˆ©√]_ E≈Õm s·∫z˛≈m ®™ AÈ™V˛≈m.  
   
 Biochemical analysis of Malaivembu Ilai Chooranam shows the presence of 
calcium, zinc which is the constituents of insulin. 
\ÁÈºkD∏_ m›>ÂVÔ ƒ›m ÷Ú©√>V_, ÷>uz \mº\Ô›]Á™  
¿¬zD zD c^·m ®™ ∂§BÈVD.  
 
 Iron and calcium are essential for nerve cells, prevents complications of peripheral 
neuritis. Malaivembu Ilai Chooranam contains iron in the form of Ferrous and it 
contains Calcium  
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 Magnesium helps to keep mind calm and nerves relaxed. This help to relieve the 
symptom, peripheral neuritis. 
 
 Flavanoids are present. Flavanoids are effective antioxidant. When body’s cells 
burn oxygen they form free radicals. Increased formation of reactive oxygen 
species (ROS) related to increase of glucose concentration in plasma and tissues. 
The inhibitory effect may be due to flavanoids. 
 
 Acute toxicity study shows Malaivembu Ilai Chooranam at the dose of 
2000mg/kg/po did not exhibit any mortality in mice. 
 
 The pharmacological study of Malaivembu Ilai Chooranam shows that it reduce 
the blood sugar levels. Hence it is proved to be good for Madhumegam. 
 
 The clinical study has been conducted under the following criteria age, sex, socio–
economic status, personal habits & diet and occupation. 
 
40 patients belonging to age group 30 to 70 were selected  
Polyuria decreased in 36 patients within 2 weeks.  
Polydipsia decreased in 34 patients within 2weeks 
Polyphagia decreased in 30 patients within 2 weeks 
 Giddiness relieved in 23 patients within 2weeks 
 Fatigue relieved in 30 patients within 3 weeks. 
 Peripheral neuritis relieved in 11 patients within 6 weeks. 
 
 Male, Middle class & rich people, 40 to 60 years age group, housewives 
alcoholics, non – vegetarians and businessmen are mostly affected. 
 
 From the above studies Malaivembu Ilai Chooranam has been proved to be 
clinically effective against Madhumegam. 
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SUMMARY AND CONCLUSION 
 
1. The trial drug Malaivembu Ilai Chooranam has been selected for anti diabetic 
activity based on strong literary evidence. 
 
i) After obtaining guidance for the Head of the department and permission from 
principal, Government siddha medical college. Pharmacological study was 
carried out in C.L. Baid Metha college of pharmacy, Thoraipakkam, Chennai. 
ii) The single drug was prepared as chooranam then purified and stored. 
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2. Phytochemical tests showed the presence of alkaloids, flavanoids, tannin and 
phytosteroids 
 
3. Rf  values were determined by Thin Layer Chromatography. 
 
4. Antimicrobial study proved that Malaivembu Ilai Chooranam was an effective anti 
bacterial agents. 
 
5. Bio-Chemical analysis shows the presence of elements like zinc, calcium and Iron 
(Ferrous). 
 
6. Malaivembu Ilai Chooranam at the dose of 2000mg/kg/po did not exhibit any 
mortality in mice.  
 
7. Animal experiments revealed that  this drug is effective in controlling blood sugar 
levels significantly when given in a dose of 500mg bds with water before food.  
8. Clinical trial showed that Malaivembu Ilai Chooranam is effective in reducing both 
the fasting and postprandial blood sugar levels. It was done in Arignar Anna Hospital 
of Indian medicine, Chennai – 106. 
 
9. The statistical analysis also significantly shows the reduction of symptoms like 
polyuria, tiredness, polydipsia, polyphagia, giddiness and peripheral neuritis. 
 
10. The administration of Malaivembu Ilai Chooranam for 48 days did not produce any 
side effects. Out of 40 patients 33 patients showed better response in reduction at 
symptoms like polyuria, polydipsia, polyphagia, fatigue and giddiness. Moderate 
response in peripheral neuritis.  
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11. The trial drug is available at everywhere in all seasons. The preparation and 
preservation of the trial drug is simple and economical. So it is concluded that 
Malaivembu Ilai Chooranam has antidiabetic activity and moderately  effective for 
controlling blood sugar levels. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AIM AND OBJECTIVES 
 
AIM :  
 
 To prove the efficacy of Paavana Omum in the treatment of Gunmam.  
 
OBJECTIVES :  
 
 The effect of salts in Siddha system of Medicine is well known one.  
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 Paavana Omum is good medicine for  the gunmam. This medicine is in the Siddha 
text, “Praana rakhsamirtha sindhu”. The ingredients of Paavana Omum are Omum, 
Induppu, Buttermilk and Lemon Juice.  
  
 The dissertation deals with the action of Paavana omum in the treatment of 
Gunmam for the case study of 48 days.  
 
 In this aspect Paavana omum was subjected to the following studies.  
 
1. Antimicrobial Study  
2. Biochemical Study  
3. Pharmacological study  
4. Clinical Study  
 
 
 
 
 
 
REVIEW OF LITERATURE 
÷Õm©A (Rock Salt) 
SIDDHA ASPECT 
 
ºkÆÿ√BÏÔ^ : 17 
  ÁƒÕ>kD    ƒÕ]ÈÔD  
  EÕ#´D   ÂVÔ ÿÂF  
  ƒÕ]´–©A    s›>ÔD  
  \]•©A    \]ÈkD  
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  \]ÌÏÁ\    ÔΩ\VƒD  
  tÕ>Vﬂ ÿƒV_   ÔV´¬ÔﬁƒV´D  
  \V[ÔƒD    √M¬ÌÏÁ\ 20 
  ÂVÔÿ>FkD18   \V¬ÔƒD  
  kVË  
 
"" √ΩBV™ kVË, \´¬Ôƒÿ\[ÆD º√Ú  
 √ˆkV™ ÁƒÕ>Èkÿ\[ÆD º√Ú  
  ƒΩBV™ ƒÕ]ÈÔÿ\[ÆD º√Ú,  
  ƒVÏkV™ ÂVÔÿÂFÿB[ÆD º√Ú,  
   ÿkΩBV™ s›>Ô ÿ\[ÆD º√Ú  
 s·∫Ôº™V \]Èkÿ\[ÆD º√Ú  
    ÔΩBV™ ÔΩ \Vƒÿ\[ÆD º√Ú  
 ÔV´¬ ÔﬁƒV´Ô ÷Õm©∏™¶© º√º´''  
     á √]ÿ™ı E›>ÏÔ^ \Ú›mk ∂Ô´V] 
 
 
 
 
 
÷Õm©∏[ º>Vu≈D: 19 
 
 ÷À°©Á√ EÕm º>ƒ›]KD, √ﬁƒV© k¶º\uz© √VÔ∫πKD ØtloÚÕm  
ÿk‚Ω   ®|¬˛[≈VÏÔ^.  ÷m  2   x>_  10   √°ı| WÁ≈•^· Ô‚ΩÔ·V•D,  
º\u√¬ÔD ∂ø¬z© √ΩÕ> Ô∏È W≈\V•D, c‚√¬ÔD ÿkıÁ\BV•D, kVloΩ_ c©√V
•tÚ¬zD. Â_È ÿkıÁ\ W≈D ÿÔVı¶m E≈Õ>>VzD.21  
 
Ák©A xÁ≈ : 19 
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 ƒx›]´ ¿Ï, 100 √ΩÁB© (200 o‚¶Ï) Amﬂƒ‚Ωlo‚|¬ ÔVFﬂE c©ÿ√|›m, ÷À°
©∏_ ±Æ √ÈD (3,500 ˛.˛´VD) ∂ΩÔ™›]Ú¬zD ƒ‚Ωlo‚|, ÔÚD√VÁÈ ∂|©∏[ *m 
Ák›m¬ ÔV¶V¬˛MBVF ®ˆ¬Ô, c©A cÚzD. ∂ﬂƒ\B›]_  
ÿkΩ•©A 5 √ÈD (175 ˛´VD), Ê™V¬ÔV´D 5 √ÈD (175 ˛´VD), Ø¿Æ 3 √ÈD  
(105 ˛´VD) ÷ÁkÔÁ·© ÿ√VΩ›m› #s Œ[Æ√¶ cÚE¬ zπ´ s‚ÿ¶|¬Ô Ô‚|D, cÁ¶
›m© √VÏ¬˛_ Ák´D º√VoÚ¬zD, ÷]_ √ﬂÁƒ¬ÔuØ´D \Ω•D, Ø´D  
x©√VzD.  
 
ºkÆ:  
 Ê™D, Ô_K©A, ÿkΩ•©A, ÿk∫ÔV´D, ∑›> ¿Ú©A x>oBÁkÔÁ·¬ ÔøÁ>  
J›]´›]KD, √∑s[ ºÔV\B›]KD ∂Á´›m ®ˆ›m ÷≈¬zD ÿ√Vøm 1/2 √∫z  
Ø¿Æ º√V‚| J¶ ∂™o_ ÿkD∏ ÷Õm©√VzD.  
 
ÿ√Vm¬zD : 19 
 "" ∂‚¶z[\ \Õ>D ∂EÏ¬Ô´ﬁÛÏ Ê>∏›>Õ  
    m‚¶ÁkBD ÂVΩ©Aı º¶V¶∫Ô^ á ÿÔ‚¶\È¬  
         Ô‚|s¶ sÕÁ>B¬ ÔVtBºÂVF k[Ô´©√V[  
         s‚|s¶ sÕm©Á√ s^.''  
 
÷Õm©∏™V_ ®ıs> z[\D, ∂ÈƒD, ∂EÏ¬Ô´D, Ô√∏›>D, Ô√V]¬ÔD,  
Â´DA¬˛´Õ], ]ˆº>V≠D, \È√Õ>D, s≠\∑¬˛ÈD, Ô´©√V[ ¿∫zD.  
 
"" ÿƒ[M¬ÔıV √uGÏ ÿƒsÔ°^Ôı ¶D√ÔºÂVF  
               ƒÕWBV ƒ∫ÔVƒÕ >VÔtÁ´© á A[M´›>  
   JÈﬁ EÈÕ]Âπ JΩÔÂﬁ ÛÁ> k_o  
    ÛÈﬁ EÁ>•tÕ>Vu ÿƒV_''   
 
÷Õm©A >ÁÈ, sa, ÂV°, >Õ>JÈD, ÔVm, Ôı¶D, ºBVM x>oB  
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÷¶∫Ôπ_ ÔVb˛[≈ ºÂVFÔÁ·•D, ƒÕWBVƒD, ºÂ›]´ÔVƒD, >VÔ∑´D, ∑kVƒD, ÷´›> 
JÈD,EÈÕ], º>^, ®o ÷ku§[ s≠∫ÔÁ·•D, kV>¬Ô|©A,z›>_  
x>oB º´VÔ∫ÔÁ·•D ¿¬zD.   
 
ÿƒFÁÔ 19  
 √E›y›#ıΩ  
 ∂Ô‚|kV•kÔu§  
 EÆ¿Ï©ÿ√Ú¬˛  
 \ÈÔVˆ  
 ÂVE¿ÏsÏ›]M  
 
√ﬁƒØ>¬ ÌÆ :  
 ÷m \ıØ>ﬂ ƒ´¬z  
 ÿ√ı ƒ´¬z  : ÷Õm©A  
÷>uz gı ƒ´¬z   : √ﬂÁƒ¬ ÔuØ´D  
 t›mÚ    : Ø´›][ t›mÚ  
 
∑›] xÁ≈Ô^ : 19  
 1. ÷>Á™¬ ÔVΩl_ J[Æ ÂV^ ª≈©º√V‚| ÛˆB[ Œπl_ cÈÏ›]  
               ®|¬Ô ∑›]BVzD.  
 2. ÿk^·V‚| ¿ˆ_ J[Æ ÂVaÁÔ \›]›m ÿkFlo_ cÈÏ›]¬ ÿÔV^·  
                ÷m ∑›]BVzD.  
 3. ÔVΩl_ ÔÁ´›m kΩÔ‚Ω ÛˆB Œπl_ ÔVBÁk›m ®|¬Ô cÁ≈Õm  
    ∑›]BVzD.  
 
Âﬁ∑ x§° :  
 ÷Õm©Á√ tz]BVÔ √B[√|›]™V_ ∏›>›Á> k·Ï¬zD. ∂]ƒV´›Á>    º>VuÆ
s¬zD.  
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 ÷>™V_ º>V[§B m[√∫Ô”¬z >VwD Øs_ c^· √z]l[ ƒVÆ         x§©√V
zD.  
 
CHEMICAL ASPECT OF ROCK SALT 
 
Chemical Name : Sodium Chloridum Impura  (NaCl) 23  
 
Vernacular Names : 23  
 English   - Rock Salt, Sea salt, Bay Salt, Sodium Chlorate.  
 Hindi  - Sendhalon, Sedhalon  
 Malayalam - Intu-uppu  
 Sanskrit - Saindhava  
 Telugu - Saindhalavanam  
 Tamil  - Indu-uppu  
 
Characters: 23 
 
 It is found in small white crystalline grains or transparent cubes. It is brownish 
white externally and white internally. It has a pure saline taste and burns with a yellow 
flame. It is colourless when pure but after tinged grey, blue,. brown or pink, because of 
associated impurities.  
 
Specific gravity: 24  
2.1-2.6, H-2.5, nD 20°, 1.5444 
Composition of Rock Salt:  
 NaCl  
 Ca (So4)2 
 CaCl2 
 MgCl 
 NaHCO3 
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 Insoluble Matter  
 Moisture  
 
Solubility : 23  
 35.7g/100g of water at 0°C 
 39.8g/100g of water at 100°C  
 
Actions: 23  
 In Small doses 
  Highly Carminative  
  Stomachic  
  Digestive  
 
 It promotes the appetite and assists digestion and assimilation.  
 In large doses  
1-2 dranchms – It is cathartic  
  4-8 dranchms – It is emetic  
Rock  Salt possess stronger purgative properties than cream of tartor.  
 
Properties and uses: 23 
 
 
 It is given in dyspepsia and other abdominal disorders. A medicinal salt called 
Nariekelashora is highly recommended in Chakaradatta as valuable in the form of 
dyspepsia which is attended with pain two or three hours after meals.  
÷Õm©A ºƒÚD \ÚÕmÔ”^ z[\ºÂVF yÏ¬zD \ÚÕmÔ^  
 
1. ∂¬M \Õ>V]ﬂ Û´D : 27  
 ÷Õm©A   1 √ÈD  
x[Á™ ºkÏ  2 √ÈD  
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 Ê´ÔD  3 √ÈD  
 {\D  4 √ÈD  
 ∑¬z   5 √ÈD  
 ]©∏o 6 √ÈD  
 
 ÷ÁkÔ”¬z ƒ\ ®Á¶ Ô|¬ÔVF ºƒÏ›m Û´D ÿƒFB°D. 
∂·°  : ÷ÚÔΩ  
∂–√V™D    : ÿkÕ¿Ï  
yÚD ºÂVF : z[\D yÚD  
  
2. z[\ zº¶Vˆ ºÈ˛BD : 22  
 ÷Õm©A  
 kÁ·BK©A  
 ÂkVﬂƒV´D  
 ÿkΩ•©A   kÁÔ¬z 1 √ÈD  
 ºƒVuÆ©A  
 ∑›]›> Ø¿Æ  
 ÔuØ´D  
 
 ÷ÁkÔÁ· Û´D ÿƒFm, ∏[ 10 √ÈD √Á™ÿk_È›]_ 1/2 √Ω  
ÿk^·V‚| ¿Ïs‚| ∂Á´›m kΩÔ‚Ω, ∂|©º√u§ EÆyBVÔ ®ˆ›m √Vz√>D  
kÚD º√Vm Û´›Á> ÿÔVﬁƒD ÿÔVﬁƒ\VÔ º√V‚| ˛·§ g≈s‚| ∑´ıΩ  
®|›m º√V]B ∂·° º>[,ÿÂF Ì‚Ω© ∏ÁƒÕm Ák›m¬ ÿÔV^· ºkı|D.  
∂·°  : ∑ıÁ¶, ÷ÚºkÁ·,  
 
yÚD ∏ËÔ^ :  
z[\D 
∂˝´D 
 kluÆ©ÿ√VÚ\_.  
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3. kÎ˜´k_o k¶ÔD 27  
4. ƒ´º√Õ]´ zπÁÔ 27  
5. ÷´ƒºBVÔ \V›]Á´ 27  
6. Ìi√Vı¶ ºÈ˛BD 27  
7. kV•s·∫ÔV]ﬂ Û´D 27 
8. ÔÚ∫ºÔVaﬂÛ´D 27 
9. √ﬁƒÈk¬Ô‚| 28  
10. √V¸Ô´ ÈkD29  
11. ÂkEﬁƒ´≥V´ k¶ÔD 30  
12. z¬˛ÈV] \V›]Á´30  
13. ∞´ı¶›Á>ÈD 30 
14. ºÔV¶VÛa \V›]Á´ 30 
15. √ﬁƒÔÀsB ˛Ú>D 30  
16. ykV¬˛Mﬂ Û´D 30 
17. z\ˆ √u√D 30 
18. √ﬁƒÈkﬂ Û´D 30 
19. ƒ∫Ôz¶Vˆ zπÁÔ 30 
20. ÿ√Ú∫ÔVBﬂ Û´D30  
21. \ÔV∑Õ>ˆ ÷´ƒD 31 (i) 
22. ÔV\Ô·V ´ƒD 31 (i)  
23. ÷´ƒ©√>∫ÔD 31 (i) 
24. s¶VtÏ> Á\ 31 (ii) 
25. ÿÔ·ˆEÕ>V\Ë ´ƒ ÿƒÕ#´D 31 (ii) 
26. Ô™Ô ÷o∫Ô ÿ\øz  31 (iii) 
27. º√Vƒ™ ƒﬁÊs 31 (iii) 
28. √ﬁƒ ÷Èk √u√D 31 (iv) 
29. \ÔV ]´VkÔD 31 (iv) 
30. ÷ÈkV]¬ zwDA 31 (iv) 
31. ÿkΩ•©A¬Ô‚| 31 (iv) 
 68
32. ÿkΩ•©A›]´VkÔD 31 (iv) 
33. >VDØ´© √u√D 32  
34. ƒmÏ xÔﬂ Û´D 32   
35. ∂¤º\V>Vi¶Ô \V›]Á´ 28 
36. WÈkVÁÔﬂ Û´D 30  
]ˆÔ|z 
ÔÚﬁÊ´ÔD 
Ê´ÔD 
÷Õm©A 
ÿ√Ú∫ÔVBD  
 
kÁÔ¬z 1 √ÈD, WÈkVÁÔ 4 √ÈD ŒÀÿkV[Á≈•D >M›>MBVÔ Û´D ÿƒFm
 ÔÈÕm ŒÚ ÿkÚÔΩ©∏´\VD ÿkÕ¿ˆ_ cı z[\D yÚD.  
 
 
 
 
 
 
 
 
 
 
{\D  
 
Botanical Name  : Carum copticum (Trachyspermum ammi)  
Family   : Umbelliferae  
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Vernacular Names : 25  
 Hindi   - Ajowan, ajwain 
 Bengali - Jowan, Juvani,  
 Marathi  - Owa, Vova 
 Gujarati - Ajamo, Yavan 
 Telugu  - Vaamu  
 Tamil   - Omum, Asampadam.  
 Kannadam - Oma, Omakki, Omu.  
 Malayalam - Omum, Ayamodakam 
 Trade  - Ajowan, Omum  
 English  - The Bishops Weed   
 
Properties and Uses: 25  
 1. It is a household remedy for indigestion.  
 2. Actions:   
        Antispasmodic  
           Stimulant  
           Tonic  
           Carminative  
3.  It is administered in flatulence, atonic dyspepsia and diarrhoea, and often 
recommended for cholera.  
4. Ajowan is also effective in relaxed sore throat and in bronchitis and often 
constitutes an ingredient of cough mixture. 
5. Taken with buttermilk, it is a common remedy for relieving difficult 
expectoration due to driedup phlegm.  
6. It has been shown to possess antibiotic activity against 
Salmonella typhosa 
Micrococcus pyogens var. aureus 
Escherichia Coli. 
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7. The roots of ajowan plant are reported to possess diuretic and  
carminative properties and are used in febrile conditions and in stomach disorders.  
8. Ajowan oil is an expectorant in emphysema, pneumonia and some other 
respiratory ailments. It has a anti-diuretic action.  
9. It is an hypotensive agent. It is a powerful antiseptic.  
         10.The aqueous portion, left after the separation of essential oil from the steam 
distillate of ajowan, is used  under the name of omum–water. It is prescribed as a 
carminative and is believed to be useful in flatulence and gripe, especially in children.  
 
˛Á¶¬zD ÷¶D : 26 
 ÷Õ]BVs_ √lˆ¶©√|˛[≈ ŒÚ ÿƒΩ kÁÔ gzD.  
 
√B[√|D cÆ©A : 26 
 sÁ>  
∑Ák :  
 ÔVÏ©A  
>[Á\ :  
 ÿk©√D  
∏ˆ° :  
 ÔVÏ©A  
ÿƒFÁÔ : 26 
 √E›y›#ıΩ  
 ÷EkÔu§  
 ∂Ô‚|kVFkÔu§  
 ∂øÔÈÔu§  
 ÿk©√xı¶V¬˛  
 c´\V¬˛  
 ctμ¿Ïÿ√Ú¬˛  
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{\ ∑›] : 27  
 ∑ıVDÁ√ ¿ˆ_ ÔÁ´›m ¿Á´ \‚ΩKD ÷Ú›] ∂]_ {\›Á> 1 ƒV\D  
xøkmD ª≈Ák›m cÈÏ›] ®|¬Ô ∑›]BVzD.  
 
zD : 26 
 "" Ê>∑´∫ ÔVƒﬁ ÿƒˆBV\Õ >Dÿ√VÚ\_  
   º√]lÁ´ﬂ ƒ_Ô|©A º√´V\D á {]Ú\_  
   √_ÿÈV|√_ JÈD √ÔtÁkºÂV ÿB[ÿƒ•º\V 
   ÿƒV_ÿÈV|º√VD {\ ÿ\™ﬂ ÿƒV_.''  
 
ÿ√Va©AÁ´: 26 
 nB∑´D, ÷Ú\_, ÿƒˆBV\Õ>D, ÿ√VÚ\_, Ôaﬂƒ_, ªa, z¶oÁ´ﬂƒ_,  
÷Á´©A, √_ ºÂVF, √ÔD (zFB º´VÔD) ÷ÁkÔ^ º√VzD.  
 
kw¬z :  
 1. {\D, ∑¬z, E›]´JÈ ºkÏ©√‚Á¶ ÷DJ[ÆD {ÿ´Á¶ ®|›m ÿ√VΩ›m  Œ[ÆÔ
ÈÕm, ÔÈÕ> ®Á¶¬z, ºÂÏ, Ô|¬ÔVF ÿ√VΩ Ì‚Ω ºkÁ·¬z Js´_ ∂·° º\Vˆ_ ÿÔV|
¬Ô, \Õ>D ¿∫zD.  
 2. {\D, Ô|¬ÔVF› º>V_, x¬Ô|z, Eu≈´›Á>, ∂¬˛´ÔV´D, ]©∏o ºkÏ ÷ÁkÔ
π[ ÿ√VΩ {ˆÁ¶ Ì‚ΩB ®Á¶¬z ºÂÏ √V], ƒÏ¬ÔÁ´ ºƒÏ›m ÔVÁÈ,\VÁÈ Js´_ ∂·
° ÿÔV^· AÁÔlÚ\_ yÚD.  
 3. {\D, t·z kÁÔ¬z 34 ˛´VD ÷kuÁ≈ ÿkm©∏, ÿk_ÈD 34 ˛´VD      ºƒÏ›>
Á´›m, ÔVÁÈ, \VÁÈ, 10 ÂV^ ÿÔV‚Á¶© √V¬Ô·° ƒV©∏¶, kluÆ¬Ô|©A,ÿ√VÚ\_, Ô
aﬂƒ_ yÚD.  
4.  {\D 252 ˛´VD, g¶Vº>VÁ¶ﬂ ƒVÆ, ÷ﬁE´ƒD, √w´ƒD, A]™VﬂƒVÆ     kÁÔ¬
z 136˛, ÷Õm©A 34 ˛´VD ºƒÏ›m ª≈Ák›m cÈÏ›] ÷Ú\_,                   ∑kVƒÔVƒD, 
∂Ê´D x>oB™ ¿∫Ô¬ÿÔV|¬ÔÈVD.  
5. {\›yˆ™V_ ªa, kluÆ©ÿ√VÚ\_, kluÆko, ÿƒˆBV¬Ôaﬂƒ_,      \Õ>D 
÷ÁkÔÁ·© º√V¬zD.  
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 The glycosidal fraction, essential oil and total oil produce contraction of 
isolated ileum, tracheal chain and bronchial musculature. Essential oil and 
total oil caused marked fall in blood pressure in cat. 
- (Indian journal med. Res. 1962 P. 55, 1003) 
 
 Thymol ( 61.0), P-cymene ( 15.6), S-terpinene ( 11.9 % ) determined in 
fruit essential oil from  Turkish plant. ( J. Essent Oil Res 1993, 5,105; Chem, 
Abstr. 1993, P118) 
      - Compendium of Indian Medicinal Plants 
          Rastogi, B.N. Mehrotra Volume I 
 
 
 
 
 
 
 
 
 
®KtﬂÁƒ 3  
 
Botanical Name : Citrus limon. Linn 
 
÷m    8á10   ∂Ω   cB´D   k·ÚD.   ÷ÁÈ,   º\uA≈D √∑Á\•¶–D, EÆ  
A^πÔÁ· cÁ¶B>VÔ°D ÷Ú¬zD. ÷©A^πÔπ_ ®ıÿF WÁ≈Õ]Ú¬˛≈m.  
 √w›][ ∑Ák   :  Aπ©A  
 >[Á\   : ÿk©√D  
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 ∏ˆ°    : ÔVÏ©A  
 ÿƒFÁÔ    : zπÏﬂE•ı¶V¬˛  
zD :  
 x¬zu≈D, ÛÁÈ, kVÕ], z[\D, ÷|\ÚÕm, ∂w_ ÷ÁkÔÁ·© º√V¬zD. 
 
Limes 24 are rich in vitamins, minerals and alkaline salts but not in fruit sugars.  
It is a good source of Vitamin C. It is considered aperient, astringent, antipyretic 
and sedative. The fruits are regarded as antiseptic, styptic and sudorific.  
 
 
º\VÏ 13  
 
c° xΩs_ º\VÏ ºƒÏÕ> c° cı√m >tμÂV‚Ω_ kw¬Ô›]_        ÷Ú¬˛
[≈m. ÷m \ÈƒÈ¬ Ô‚| cı¶VÔV\_ c¶_ ÿk©√›Á> >Ë¬zD.  
 
√E\Õ>›]uz √›]B©ÿ√VÚ·VÔ kw∫Ô©√|˛≈m.   
 
 
 
{\D ºƒÚD \ÚÕmÔ”^ z[\ºÂVF yÚD \ÚÕmÔ^ :  
 
1. ÷ÈÕÁ> ÿÂF 33 
2. ƒV´Á ÿÂF34 
3. ÔÚﬁƒV] ÷ÈkD 34 
4. ÿÔV[Á≈ ÿÂF34 
5. ∂Ô›]BÏ ºÔV¶VÛa \V›]Á´ 35 
6. z[\ﬂ Û´D 34 
7. Ô|¬ÔVF ÷·ÔD 34 
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8. k·´V˛ kÁ·BD 36 
9. ´V¤ƒ∫zkΩ \V›]Á´  28 
10. «ˆ>˛ ºÈ˛BD 27 
11. Ôˆ©√™Vz ºÈ˛BD 27  
12. kÎ˜´k_o √Vz 27 
13. gl_√‚Á¶ﬂ Û´D 37  
14. \ÔVs_kV] ºÈ˛BD 28 
15. kﬂE´k_Èˆ>˛ ºÈ˛BD  27 
16. ƒ∫Ô ≥V´D 30  
17. kﬂE´ k_o¬ Ô|z 30 
18. √ﬁƒÈkﬂ Û´D 30 
 
 
 
 
 
 
 
 
z[\ºÂVF yÏ¬zD ∏≈ \ÚÕmÔ^  
 
1. ∂tÈ√u√ \V›]Á´ 31 
2. ∂i¶ÔuØ´D31 
3. Âk c©A ÿ\øz 19 
4. z[\›]uzﬂ Û´D 27 
5. ∞ÈV] Û´D 14 
6. c©Aﬂ ÿƒÕ#´D 14  
7. z[\zº¶Vˆ ÿ\øz 14 
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8. ÔVs¬Ô_ Û´D 19 
9. ƒ©>Èk √u√D 38  
10. ÔwuE Ô≠VBD 21 
11. ÂV_√V\´V] ÿÂF21 
12. EkÁ> ºkÏ Û´D 21 
13. ]ˆ√ÈV Ô≠VBD 21 
14. z\ˆºkÏ¬ Ô≠VBD21 
15. ∏´ıÁ¶ ®[ÿF21 
16. ÿƒÀsBV] ÿÂF 21 
17. ƒ∫Ô¶ ƒV´ \V›]Á´ 21 
18. z[\koﬂ ÿƒÕ#´D 21 
19. kƒV] ˛Ú>D 21 
 
 
 
 
 
 
MATERIALS AND METHODS 
 
PREPARATION OF CHOORANAM: 
 
 The trial drug Paavana omum was taken from a siddha literature, “Praana 
rakhsamirtha sindhu” 28 
 
COLLECTION OF THE DRUG: 
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 The raw drugs, which are the ingredients of Paavana omum, were collected from 
the raw drug shop. 
 They were identified and confirmed by the guide. 
 
STORAGE OF CHOORANAM: 
 
 Medicine was stored in the airtight glass container. 
 
PURIFICATION OF ALL INGREDIENTS: 
1. ÷Õm©A : 19  
 ÷>Á™ ÔVΩl_ J[Æ ÂV‚Ô^ ª≈©º√V‚|, ÛˆBÿ™Vπl_ cÈÏ›]  
®|¬Ô ∑›]BVzD.  
 
2. {\D: 3  
 {\›Á> Ôu∑ıVDA ¿ˆ_ 1 ƒV\D ª≈Ák›m, ∏≈z ®|›m Ôøs  
cÈÏ›]¬ ÿÔV^· ºkı|D.  
 
 
 
\ÚÕm ÿƒF•D xÁ≈ :  
 ∂Á´ √∫z {\›][ ∂ˆEÁB ŒÚ ÂV^ Aπ›> º\Vˆ_ ª≈Ák›m            cÈÏ›
], ∏≈z 1 √∫z ®KtﬂƒD √wﬂƒVÆD, 1/4 √∫z ÷Õm©AD ºƒÏ›m ∂]_        2 ÂV^ ª≈Á
k›m cÈÏ›] ®|›m¬ÿÔV^· ºkı|D.  
 
∂·° : 1 ˛´VD , 2 ºkÁ· 
∂–√V™D : >ıßÏ 
yÚD ºÂVFÔ^:  
 z[\D, ∂˝ÏD, kluÆko, ∂¬˛M\Õ>D, klÆ©√_ x>oB              ºÂVFÔ
^ z\VzD.  
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METHODOLOGY FOR ANTI-MICROBIAL STUDY 
 
METHOD: 
 
 The anti-bacterial activities of different extracts of Paavana Omum were studied 
by disc diffusion method against the following organisms. 
1. Streptococcus mutans 
2. Staphylococcus aureus 
3. Escherichia coli 
4. Klebsiella pneumoniae 
5. Pseudomonas aeruginosa 
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Extracts of Paavana Omum were used in the concentration of 10, 50 and 25 µl 
using their respective solvents.  Ciprofloxacin ( 50 mcg / disc ) was used as standard. The 
disc diffusion method was employed for the screening of               antibacterial activity. 
 
DISC DIFFUSION METHOD:  
 
 A suspension of organism was added to sterile soya bean casein digest agar media 
at 45oC, the mixture was transferred to sterile petridishes and were allowed to solidity. 
Sterile discs, 5 mm in diameter, dipped in solutions of different extracts, standard and a 
blank was placed on the surface of agar plates.  The plates were left standing for one hour 
at room temperature as a period of preincubation diffusion to minimize the effects of 
variation in time between the application of the different solutions.  Then the plates were 
incubated at 37o C for 18 hours and observed for anti-bacterial activity.  The diameter of 
zones of inhibition were observed and measured.  The average area of zones of inhibition 
were calculated and compared with that of standard’s. 
 
RESULT FOR ANTI MICROBIAL STUDY OF  
PAAVANA OMUM  
 
Organism 
Standard 
drug 
Ciprofloxacin 
50 mcg/disc 
Test drug (Paavana Omum µl/disc ) 
Zone of Inhibition in mm 
10µl 25µl 50µl 
Streptococcus  
mutans  
31 15 17 21 
Staphylococcus  
aureus 
30 12 16 19 
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Escherichia coli 32 18 22 25 
Klebsiella 
pneumoniae 
29 14 21 24 
Pseudomonas 
aeruginosa 
30 16 19 22 
 
14 mm – Low sensitive, 15mm – Moderate, above 16mm – highly sensitive.  
 
NOTE :  
SAMPLE CONCENTRATION : -  
  4gm – 400 ml of solvent in 25µl, 50µl, and 10µl/disc.  
 
Standard for Bacteria :  
  Ciprofloxacin HCL, 50 mcg/ disc 
 
Paavana Omum has highly sensitive to following organisms;   
Streptococcus  mutans 
Staphylococcus aureus 
Escherichia coli 
Klebsiella pneumoniae  
Pseudomonas aeruginosa.  
BIO CHEMICAL ANALYSIS 
 
 5gm of Paavana Omum was weighed accurately and placed in a 250ml clean 
beaker and with 50ml of distilled water. Then it was boiled well for about 10 minutes, 
then it was cooled and filtered in a 100ml volumetric flastic and made upto 100ml with 
distilled water.  
 
 Then it was undergone the following tests for the presence of Acid Radicals Basic 
radicals, and phytochemical constituents in Paavana Omum.  
 
Procedure Observation Inference 
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Test for Calcium : 2 ml of 
extract is taken in a clean test 
tube. To this add 2 ml of  4% 
ammonium oxide solution.   
 White precipitate is formed Presence of calcium  
Test for Sulphate : 2 ml of the 
extract is added to 5 % barium 
chloride solution. 
 
White precipitate is formed  Presence of Sulphate  
Test for Chloride : The extract 
is treated with Silver nitrate 
solution  
 
White precipitate is formed Presence of Chloride 
Test for carbonate : The 
substance is treated with Conc. 
HCl. 
Effervescence is formed  Presence of carbonate 
Test for Iron (Ferric) : The 
extract is treated with glacial 
acetic acid and potassium 
ferrocyanide  
 
Blue colour is formed Presence of Ferric iron 
Test for phosphate : The 
extract is treated with 
ammonium molybdate and 
conc. HNO3 
 
Yellow precipitate is formed Presence of phosphate 
Test for Tannic acid : The 
extract is treated with Ferric 
chloride  
 
Blue black precipitate is 
formed 
Presence of Tannic acid 
Test for Unsaturation : 1 ml of 
Potassium permanganate 
solution is added to the extract.   
  
Decolourised  Presence of unsaturated 
compound 
Test for amino acids: Dilute 
extract +2ml of Ninhydrin’s 
soln . 
Formation of  violet colour Presence of  amino acids 
Test for proteins: Biuret 
method ; 1ml of dilute 
extract+1mlof5%CuSO4+ 
1%NaOH. 
 
Formation of Violet colour Presence of proteins 
Test for Flavanoids : Dilute 
extract+ mg  bits+2drops of 
conc.HCl  and gently heated. 
 
Formation of pink colour Presence of Flavanoids 
Test for phenol; Dilute  Deep green colour is formed Presence of phenols 
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extract+2drops of FeCl3 soln. 
 
Test for Tannins ; dilute 
extract +2ml of 10%lead acetate 
add. 
White precipitate formed Presence of tannins 
Test for alkaloids; 
 Mayer’s method;1ml of dilute 
extract + 1ml reagent. 
 
Dragendroff’s method; 1ml of 
dilute extract+ 1ml of reagent. 
 
Appearance of cream colour 
precipitate 
 
 
 
Appearance of orange colour 
precipitate 
 
Presence of alkaloids 
 
 
 
Presence of alkaloids 
 
RESULT :  
Paavana Omum Contains,  
Acid Radicals  
 Sulphate  
 Chloride  
 Carbonate  
 Phosphate  
 
Basic Radicals  
 Calcium  
 Iron (Ferric)  
Phytochemicals:  
 Tannic acid  
 Unsaturated  
 Alkalodis  
 Steroids  
 Protein  
 Tannins  
 Phenols   
 Flavanoids  
 Aminoacid  
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 Glycosides  
 
QUANTITATIVE ANALYSIS :  
 
 
S.NO TEST PARAMETER RESULTS 
01 Copper  28.6 mg/kg 
02 Magnesium 2215mg/kg 
03 Calcium 1.24 %  
 
INFERENCE:  
 The Paavana Omum sample was found to have 28.6mg/kg of copper, 2215mg/kg 
of magnesium and 1.24% of calcium.   
 
 
 
 
 
ACUTE ORAL TOXICITY STUDY 
 
 
Acute oral toxicity43 was conducted as per the OECD guidelines (Organization of 
Economic Cooperation and Development) 423 (Acute Toxic Class Method). The acute 
toxic class method is a stepwise procedure with 3 animals of a single sex per step. 
Depending on the mortality and /or moribund status of the animals, on the average 2-4 
steps may be necessary to allow judgment on the acute toxicity of the test substance. This 
procedure results in the use of a minimal number of animals while allowing for 
acceptable data based scientific conclusion. 
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The method uses defined doses (5, 50, 300, 2000 mg/kg body weight) and the 
results allow a substance to be ranked and classified according to the Globally 
Harmonized System (GHS) for the classification of chemicals which cause acute toxicity. 
 
 
Wistar albino mice of either sex weighing 20-25 g were fasted overnight, but 
allowed water ad libitum. Paavana Omum  is relatively non toxic in clinical practice the 
highest dose of 2000 mg/kg/p.o (as per OECD guidelines “Unclassified”) was used in the 
acute toxicity study.   
 
The animals were observed closely for behavioural toxicity, if any by using FOB 
(Functional observation battery). 
 
RESULT:   
 
 Paavana Omum  at the doses of 2000mg/kg/po did not exhibit any mortality is 
mice. 
 
 
ANTI ULCER STUDY 
 
 
 Wister albino rats of either sex weighing between 200 – 250 g were assigned into 
3 groups of 6 animals each.  
 
Group I  - Received warm water served as solvent control  
Group II  - Received the Standard Drug (Ranitidine 20mg/kg/po)  
Group III - Received the test drug. (Paavana Omum)  
 
Gastric ulcers in rats were produced by 4 hrs pylorous ligation (Goel R.K, 1985). 
Briefly ulcer was induced in 18 hrs fasted rats by 4 hrs Pylorous Ligation (PL). Gastric 
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ulcer was induced by ligating the pyloric end of the stomach without causing any damage 
to the blood supply under diethyl ether anaesthesia. The animals in pyloric ligation 
induced GU were sacrificed after 4 hrs. The ulcer index in the above groups were 
calculated by adding the total number of ulcer per stomach and total severity of ulcers as 
+1 per stomach. Ulcer index was scored based upon the product of length and width of 
the ulcer present in the glandular portion of the stomach (mm2/rat).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RESULT :  
  
 
Effect of Paavana Omum on gastric ulceration induced by 4 hrs pyloric ligation  in 
rats 
 
   
Oral 
treatment 
Pyloric ligation 
                    (4 hrs) 
pH of 
samples 
 
 
Morphological 
observation of 
ulcer index  Ulcer index 
(Unit/100ml) 
% 
protection 
Control 1.52 ± 0.956 - 1.68 ± 0.241 
 
++++ 
Standard 
Ranitidine   
20mg/kg/po 
4.43 ± 0.127 66.5 5.24 ± 0.261 
 
Nil 
Paavana 3.31 ± 55.1 3.97 ± + 
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Omum 
500mg/kg/po 
0.754*** 0.136**
 
 
 
n=6; Values are expressed as mean ± S.D followed by Students Paired ‘T’ Test 
***P<0.001 as compared with control. 
 **P<0.003 as compared with control.  
 
Paavana Omum exhibited antiulcer activity in pyloric ligated rats. The ulcer 
index showed a percentage protection of 55.1% for Paavana Omum against 66.5% for 
standard anti ulcer drug Ranitidine. The gastric juice of the Paavana Omum treated rats 
showed a pH of 3.97 against the pH of control rats (1.68). There is a good correlation of 
pH and % protection of ulcer index of rats treated with both Paavana Omum and 
ranitidine. There was a complete remission of ulcer sore with respect to ranitidine where 
as Paavana Omum exhibited a morphological ulcer sore of 1+ when compared to 
control (4+). This again shows a significant antiulcer activity for Paavana Omum.  
 
METHODOLOGY FOR STATISTICAL ANALYSIS  
 
To study variation in one or more attributes the data are expressed mostly as 
proportions. If a sample is divided into only two classes such as successes and failures it 
is said to have a binomial. 
 
   Number of individuals having a Specific Character  
P =   
      Total Number  
   Character in a binomial distribution is expressed   
P =   
      Total Number  
  q = probability of non – occurrence of the same . 
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STANDARD ERROR OF PROPORTION (S.E.P)  
 
 The probability or Proportional changes of positive or negative occurrence of an attribute 
or a character in a population or universe follows. 
 
 Binomial Frequency Distribution  
      Pq  
      N  
  
Probability of difference occurring by chance can be found by applying Z test as done in 
the case of means,   
                 p – P  
   S.E.P 
 
 
 
 
STATISTICAL ANALYSIS OF SUBJECTIVE PARAMETERS OBSERVED 
BEFORE AND AFTER TREATMENT OF PATIENTS.  
 
S.No Parameters 
Percentage improved Statistical 
Criteria 
Probability Significance
Study  Effect Difference 
1. Epi gastric 
Pain  
100 95 5 Z=1.00 P<0.001 Significant  
2. Vomiting  87.5 80 7.5 Z=0.7 P<0.001 Significant  
3. Abdomial 
distension  
75 75 0 Z=1.2 P<0.001 Significant  
 
P <0.001 hence the improvement in the subjective parameters produced by Paavana 
Omum is statistically significant.  
√S.E.P =  
Z =  
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CLINICAL ASSESSMENT 
z[\D 39 
 
ºkÆÿ√BÏÔ^ :  
 z[\D 
 kluÆ^ A´·_  
 kluÆ^ A´·K¶[ ºÂV>_ 
 
÷B_: 
 ÿƒˆBVÁ\, klu§_ ®ˆﬂƒ_, kVÕ], c¶_k[Á\ zÁ≈>_, º>ÔD  
ÿ\o>_, \™D z[≈_ g˛B z§z∫Ô”Á¶Bm.  º\KD kluÆ^ c°  
ÿƒˆ¬ÔV\_ ÔVuÆ¬ÌΩ ko•¶[ √Õmº√V_ A´·ﬂ ÿƒF•D ºÂVF ®™°D,  
÷ÕºÂVBV_ kÚÕmDº√Vm \™D z[ÆD ÔV´›>VKD, ko kÚDº√Vm  
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ºÂVl™Á™ x[√¬ÔD z[≈ Ák¬zD ÔV´›>VKD ÷>Á™ z[\ºÂVF           ®[√Ï. 
 
ºÂVF kÚD ka: 
 
 "" ÿƒFBV™ z[\›][ º>Vu≈Õ >[Á™ﬂ 
  ÿƒ©∏¶ºk mkÏ©√V™ ÿ√VE© ∏™VKD 
    ÿ\FBV™ \∫ÁÔ•¶[ \Úk ÈVKD 
  kÁÔBVz∫ ˛w∫zkÁÔ BÚÕ> ÈVKD 
 cFBV™ t·z kÁÔ •Á´©∏™VKD 
  cÆ√EÁB B¶¬˛| \Õ>› >VKD 
 >FBV™ ƒı¶V· ºÔV√› >VKD 
  ƒo©√VKD z[\DkÕ >Á¶•D √Vº´''  
      á R˛ Ák›]B EÕ>V\Ë ÿ√Ú±_ 800 
 
 
1. tz]•D Û|^· ÿ√VÚ^ÔÁ·•D, ÔVuÁ≈ kluÆ^ W´©√¬ÌΩB  
ÿ√VÚ^ÔÁ·•D, \ı, ct, Ô_, #∑ ÷Ák ÔÈÕ> ÿ√VÚ^ÔÁ·•D 
 cı√>VKD. 
 
2. ∑Á™¿Ï, {‚¶\u≈ ¿Ï, ∑ıVDA ÔÈÕ> ¿Ï ÷ÁkÔÁ· ∂ÚÕ>ÈVKD. 
 
3. º>∫ÔVF©√V_ º√V[≈ ÿƒˆ¬Ô¬Ì¶V© ÿ√VÚ^ÔÁ· tz]•D 
 ÿÔV^k>VKD. 
 
4. ∂Ω¬ÔΩ E™∫ÿÔV^·_, √‚ΩM ÷Ú›>_, \™ﬂƒo©A ∂Á¶>_  
g˛Bku≈VKD ÷ÕºÂVF cı¶VzD. 
 
"" ÿ>V¶ÏkV> √Õ>\ÈVm z[\D k´Vm''  
      - º>Á´BÏ  
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 cs[ ºkÆ√V‚¶VKD, >ÔV> Â¶›Á>BVKD kπ¬zu≈D ºÔ¶Á¶Õm,  
∂>uz mÁBVÔ \u≈ ÷Ú zu≈∫Ô”D ÌΩ ÷BuÁÔ› ÿ>Va_ AˆBVm, 
ºÔ¶Á¶Õ> zu≈∫Ôπ[ ∂·kVÔ ÔV_Ô”^ ˇμºÂV¬z¬ÔV_ (∂√V™ kV•) 
º\_ºÂV¬z¬ÔV_ (c>V™ kV•), Â|¬ÔV_ (ƒ\V™[) J[ÆD ºÔ¶Á¶Õm  
÷ÕºÂVÁB cÚkV¬z˛≈m. 
 
z§z∫Ô^: 40 
¾ klÆ A´‚Ω ºÂV>_ 
¾ cs_ ÿkÆ©A 
¾ √El[Á\ 
¾ z\‚¶_, kVF¿Ï ª≈_ 
¾ ®]ÿ´|›>_ 
¾ AπºB©√D 
SELECTION OF THE PATIENTS: 
 
 In our siddha system of medicine, so many single and compound medicine are 
available for Gunmam. 40 cases were selected in the OP of Arignar Anna Govt hospital, 
Chennai – 106. 
 
INCLUDING CRITERIA 
 
¾ Age 31-70years, sex, occupation, diets, and personal habits, socio–economic 
status. 
¾ Epigastric pain 
¾ Heart burn 
¾ Regurgitation 
¾ Nausea 
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¾ Vomiting 
¾ Abdominal distension 
 
EXCLUDING CRITERIA 
 
¾ Radiating abdominal pain as in pancreatitis, appendicitis. 
¾ Acute abdominal colics. 
¾ Cancer of stomach 
¾ Complication of peptic ulcer in haemorrhage, perforation, malignancy at the site 
of the ulcer. 
 
 
 
 
 
 
INVESTIGATIONS: 
 
 The blood investigation such as HB, ESR was done in biochemical laboratory of 
Arignar Anna Hospital. Endoscopy was done in private laboratory and peripheral 
hospital.  
 Diagnosis was made on the basis of signs, symptoms and investigations. 
 
LINE OF TREATMENT 
 
 The patients were orally administered with Paavana omum of dose 1gm twice a 
day with water before food for a period of 48 days.  
 
OBSERVATION AND RESULTS OF CLINICAL STUDY 
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 The Clinical study was subjected to 40 selected cases. 
 
 The following parameters were observed during courses of treatment. 
 
¾ Age 
¾ Sex 
¾ Socio-economic status 
¾ Personal habits 
¾ Occupational status 
 
 
 
 
 
AGE DISTRIBUTION:  
 
  
S.No Age in Years No.of Patients Percentage  (%)
1. 31-40 18 45 
2. 41-50 11 27.5 
3. 51-60 7 17.5 
4. 61-70 4 10 
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AGE DISTRIBUTION
10%
17.50% 45%
27.50%
31-40 41-50 51-60 61-70
 
 
 
 
INFERENCE :  
 Among 40 Patients. 18(45%) belong to age group 31-40, 11(27.5%) patients 
belong to age group 41-50, 7(17.5%) patients belong to age group 51-60 and 4(10%) 
patients belong to 61-70. Maximum patients found to be between      31-40. 
 
 
 
 
SEX DISTRIBUTION:  
  
S.No Sex No.of.Cases Percentage  (%) 
1. Male  20 50 
2. Female  20 50 
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Male Female 
Sex
SEX DISTRIBUTION
SOCIO- ECONOMIC STATUS
12.50%
37.50%
50%
Poor Middle Rich 
 
 
 
 
 
 
 
 
INFERENCE  
 Out of 40 Patients 20 cases(50%) were male and 20 cases (50%) were female.  
 
SOCIO- ECONOMIC STATUS:  
 
S.No Socio – Economic Status  No.of.Cases Percentage  (%) 
1. Poor  20 50 
2. Middle 15 37.5 
3. Rich  5 12.5 
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HABIT WISE DISTRIBUTION 
87.5
75
25 25
0
10
20
30
40
50
60
70
80
90
100
Non – Veg Smoking Alcohol Tobacco 
Habit and Diets
Pe
rc
en
ta
ge
 
INFERENCE :  
Among 40 patients 20(50%) were poor, 15(37.5%) were middle class and 5 
(12.5%) were rich.  
 
 
 
HABIT WISE DISTRIBUTION  
 
S.No Habit and Diets  No.of.Cases Percentage  (%) 
1. Non – Veg  35 87.5 
2. Smoking  30 75 
3. Alcohol  10 25 
4. Tobacco  10 25 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INFERENCE :  
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 This table shows that food habit may be cause of Gunmam. Among 40 patients. 
35(87.5%) were Non - Vegetarian, 30(75%) were Smoker, 10(25%) were alcoholic, 
10(25%) were tobacco users.  
 
 
 
 
OCCUPATION WISE DISTRIBUTION 
 
S.No Occupation  No.of.Cases Percentage  (%) 
1. House wife 15 37.5 
2. Retired person  5 12.5 
3. Student  4 10 
4. Autodriver  4 10 
5. Business men  5 12.5 
6. Tailor  7 17.5 
 
 
 
 
OCCUPATION WISE DISTRIBUTION
12.5
10 10
12.5
17.5
37.5
0
5
10
15
20
25
30
35
40
House w ife Retired
Person 
Student Auto Driver Business
man 
Tailor 
Occupation
Pe
rc
en
ta
ge
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Inference:  
 Among 40 patients 15(37.5%) patients were housewives, 5 (12.5%) patients were 
Retired person, 4(10%) patients were Student, 4(10%) patients were Autodriver, 
5(12.5%) patients were Business men and 7 (17.5%) were Tailor.  
 
 
SYMPTOM WISE DISTRIBUTION 
 
Symptoms 
Before 
Treatment 
After 
Treatment 
Improvement
Percentage 
(%) 
Epigastric Pain 40 2 38 95 
Heart burn 27 6 21 52.5 
Regurgitation 10 6 4 10 
Nausea 35 5 30 75 
Vomiting 35 3 32 80 
Abdominal 
Distension 
30 0 30 75 
 
 
 
 
 
 
 
 
 
 
 
SYMPTOM WISE DISTRIBUTION
40
27
10
35 35
30
2
6 6 5 3
0
38
21
4
30 32 30
0
5
10
15
20
25
30
35
40
45
Epigastric
Pain
Heart burn Regurgitation Nausea Vomiting Abdominal
Distension
Symptoms 
Pe
rc
en
ta
ge
 
Before Treatment After Treatment Improvement
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INFERENCE:  
 Patients with symptoms that is Epigastric pain, Heartburn, Regurgitation, Nausea, 
Vomiting, Abdominal distension were taken for the study.  
Among 40 patients 38 patients improved from Epigastric pain. Among 27 patients with 
Heartburn 21 improved. Among 10 patients with Regurgitation 4 got relief, Among 35 
patients with Nausea 30 got improvement, Among 35 patients with Vomiting 32 got 
improvement, Among 30 patients with Abdominal distension 30 patients got 
improvement  
DISCUSSION 
 
 Today’s fast moving life style with its unhealthy food habits and increased stress 
are taking its roll on human health and among the diseases caused due to the occurrence 
of Gunmam is increasing at an alarming rate. 
 
"" ÿ>V¶ÏkV> √Õ>\ÈVm z[\D k´Vm''  
        - º>´Ï  
 
As per siddha system, gunmam is caused by derangement of vatham. 
 
 cs[ ºkÆ√V‚¶VKD, >ÔV> Â¶›Á>BVKD kπ¬zu≈D ºÔ¶Á¶Õm,  
∂>uz› mÁBVÔ \u≈ zu≈∫Ô”D ºÔ¶Á¶Õm ˇμ ºÂV¬z¬ÔV_, º\_  
ºÂV¬z¬ÔV_, Â|¬ÔV_  ®[–D ÷DJ[§[ ÿ>VaÁÈ•D ÿÔ|›m ÷ÕºÂVÁB©∏≈©∏
¬zD.  
 
 kV>›Á>  ƒ\©√|›>¬ÌΩB ∑ÁkÔ^ ÷M©A, Aπ©A, c©Aﬂ ∑ÁkÔ·VzD. 
 √Vk™ {\›][ ∑Ák, ∂]ÔD Aπ©A, EÆc©A. ®™ºk ÷Õ> \ÚÕ>V™m  
kV>¬zu≈›]Á™ ƒ\©√|›] z[\ ºÂVlÁ™ ¿¬zD.  
 Aπ©Aﬂ∑ÁkBV™m \ı \uÆD y Ø>¬ ÌÆÔ^ ºƒÏÕ>m.  c©Aﬂ 
∑ÁkBV™m ¿Ï \uÆD y Ø>¬ÌÆÔ^ ºƒÏÕ>m. ¿Ï Ø>›]uz z[\›]Á™  
¿¬zD zD cı|.   
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¾ The antimicrobial study of Paavana Omum shows that it is highly sensitive to all 
the following organisms such as,  
Streptococcus mutans 
Staphylococcus aureus 
Escherichia coli 
Klebisiella pneumoniae 
Pseudomonas aeruginosa.  
¾ Bio Chemical analysis of Paavana Omum shows the presence of Copper, 
Magnesium and Calcium which has anti ulcer property.  
>Vt´›]uz z[\›Á> sÁ´s_ º√V¬Ô¬ÌΩB >[Á\ ÷Ú©√>V_ ÷>uzz[\ 
ÔVÈ[ ®[≈ ÿ√BÚD cı|.  
The Average Concentration of copper present in normal plasma is about 100 
µg/100 ml in adults. 
 Paavana Omum contains 28.6 mg/kg copper. Copper has healing property.  
¾ The body contains about 21g of magnesium. Daily requirement of  
 magnesium  is 300 – 350 mg. Paavana Omum contains 2215 mg/kg of  
 magnesium. Magnesium neutralizes the HCL in the Stomach.  
¾ Calcium is a antacid. Paavana Omum contains 1.24% of Calcium.  
¾ Acute toxicity study shows Paavana Omum at the dose of 2000 mg/kg/po did hot 
exhibit any mortality in mice.  
¾ The Pharmacological study of Paavana Omum shows that it pacifies the acidity 
levels of the gastric juice and protects the gastric mucosa from injury. Hence it is 
proved to be good for Gunmam. At the study pH of gastric juice was 3.97±0.136. 
¾ The clinical study has been conducted under the following criteria age, sex, socio 
– economic status, personal habits & Diet and Occupation.  
¾ 40 Patients belonging to the age group of  30 to 70 are selected. 
¾ Epigastric pain decreased within 12 hours.  
¾ The heartburn relieved in 22 patients within a week.  
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¾ Regurgitation relieved in patients within a week.  
¾ Nausea & Vomiting  relieved in patients within 10 days.  
¾ Abdominal discomfort relieved in patients within a week.  
 
The clinical finding showed that the people belonging to the age group 31 to 40 years 
are mostly affected and the people of poor socio economic group, mostly of males, and 
the housewives and labours are mostly prone to gunmam. The people who have taken 
much of non-vegetarian food items and alcohol are commonly affected.  
  
Students, housewives, alcoholics, non–vegetarians, tobacco and smokers showed late 
recovery.   
 
From the above studies Paavana Omum has been proved to be clinically effective 
against Gunmam.  
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SUMMARY AND CONCLUSION 
 
¾ The trial drug Paavana Omum has been selected for its antiulcer activity bases on 
literature evidence.  
¾ Bio- Chemical analysis shows the presence of elements Copper, Magnesium, 
calcium and  Iron (ferric) 26.  
(i)  Copper has ulcer healing property. 
(ii)  Mg – Magnesium Hydroxide that neutralize the HCL.  
(iii)   Ca is in the form of CaCl2 in the stomach. It is a antacid.          
¾ Animal experiments revealed that drug has a ulcer healing property when given in 
a dose of 500mg bds with water before food.  
¾ Clinical trial showed that Paavana omum is effective.  
¾ The Statistical analysis also significantly shows the reduction of symptoms like 
epigastric pain, heartburn, regurgitation, nausea, vomiting and abdominal 
distension.  
¾ The administration of Paavana Omum for 48 days did not produce any        side 
effects.  
¾ Out of 40 patients, 30 patients showed better response in reduction at symptoms 
like epigastric pain, heartburn, regurgitation, nausea, vomiting, and abdominal 
distension.  
¾ So it is concluded Paavana Omum has antiulcer activity.  
 
 
S. 
No 
Op 
No 
Name/ 
Age/ Sex Complaints Days 
 
 
BT
AT
Investigation 
 
 
Endoscopy
 
 
Results 
Blood 
Serum 
cho. 
Urine 
TC 
DC ESR 
Hb Sug Urea Alb Sug Dep 
P L E ½ hr
1 
hr
1. 5100 Chellammal  40/ F 
Epigastric 
pain, heart 
burn, 
regurgitation, 
nausea, 
vomiting.  
48 
BT 
 
 
 
AT 
10400 
 
 
 
10300
63 
 
 
 
55
35 
 
 
 
35
2 
 
 
 
3 
4 
 
 
 
3 
8 
 
 
 
6 
11.5 
 
 
 
11 
110 
 
 
 
115 
18 
 
 
 
19 
165 
 
 
 
160 
Nil 
 
 
 
Nil 
Nil 
 
 
 
Nil 
Few 
Epi.cells 
 
 
Few 
Epi.cells 
Gastritis  
 
 
 
Normal  
Symptoms 
Relieved   
2. 5112 Gopinath  45/ M 
Epigastric 
pain, heart 
burn, nausea, 
vomiting, 
abdominal 
distension.  
48 
BT 
 
 
 
AT 
10500 
 
 
 
10900
57 
 
 
 
55
35 
 
 
 
33
2 
 
 
 
7 
4 
 
 
 
3 
8 
 
 
 
5 
12 
 
 
 
12.5
115 
 
 
 
100 
20 
 
 
 
15 
170 
 
 
 
165 
Nil 
 
 
 
Nil 
Nil 
 
 
 
Nil 
Few 
Epi.cells 
 
 
Few 
Epi.cells 
- 
 
 
 
- 
Moderate 
response 
3. 5148 Nambirajan  64/ M 
Epigastric 
pain, 
regurgitation, 
nausea, 
vomiting, 
abdominal 
distension.  
48 
BT 
 
 
 
AT 
10600 
 
 
 
10600
55 
 
 
 
55
35 
 
 
 
39
3 
 
 
 
5 
5 
 
 
 
4 
10 
 
 
 
6 
12 
 
 
 
12.5
100 
 
 
 
100 
25 
 
 
 
20 
150 
 
 
 
150 
Nil 
 
 
 
Nil 
Nil 
 
 
 
Nil 
Few 
Epi.cells 
 
 
Few 
Epi.cells 
Gastritis  
 
 
 
Normal  
Symptoms 
Relieved   
4. 5806 Kumar  25/ M 
Epigastric 
pain, heart 
burn, 
abdominal 
distension.  
 
48 
BT 
 
 
 
AT 
9800 
 
 
 
10400
65 
 
 
 
50
33 
 
 
 
35
5 
 
 
 
4 
7 
 
 
 
3 
9 
 
 
 
6 
12 
 
 
 
13 
98 
 
 
 
96 
16 
 
 
 
20 
175 
 
 
 
165 
Nil 
 
 
 
Nil 
Nil 
 
 
 
Nil 
Few 
Epi.cells 
 
Few 
Epi.cells 
- 
 
 
 
- 
 
Moderate 
response   
5. 5930 Naveena  28/ F 
Epigastric 
pain, heart 
burn, nausea, 
vomiting, 
abdominal 
distension.  
48 
BT 
 
 
 
AT 
10600 
 
 
 
10700
57 
 
 
 
55
35 
 
 
 
35
4 
 
 
 
4 
5 
 
 
 
4 
9 
 
 
 
6 
13 
 
 
 
13 
120 
 
 
126 
18 
 
 
 
20 
180 
 
 
 
150 
Nil 
 
 
 
Nil 
Nil 
 
 
 
Nil 
Few 
Epi.cells 
 
 
Few 
Epi.cells 
- 
 
 
 
- 
Symptoms 
Relieved   
6. 8722 Rajathi  45/ F 
Epigastric 
pain, 
regurgitation, 
nausea, 
vomiting, 
abdominal 
distension.  
48 
BT 
 
 
 
AT 
10800 
 
 
 
10900
55 
 
 
 
55
35 
 
 
 
33
4 
 
 
 
3 
2 
 
 
 
2 
4 
 
 
 
4 
13 
 
 
 
14 
100 
 
 
 
100 
20 
 
 
 
25 
150 
 
 
 
160 
Nil 
 
 
 
Nil 
Nil 
 
 
 
Nil 
Few 
Epi.cells 
 
 
Few 
Epi.cells 
- 
 
 
 
- 
Symptoms 
Relieved   
7. 4856 Ramasamy  28/ M 
Epigastric 
pain, 
regurgitation, 
heart burn, 
nausea, 
vomiting. 
 
48 
BT 
 
 
 
AT 
10700 
 
 
 
10800
51 
 
 
 
50
34 
 
 
 
34
4 
 
 
 
2 
7 
 
 
 
4 
9 
 
 
 
4 
14 
 
 
 
14 
110 
 
 
 
110 
26 
 
 
 
30 
170 
 
 
 
170 
Nil 
 
 
 
Nil 
Nil 
 
 
 
Nil 
Few 
Epi.cells 
 
 
Few 
Epi.cells 
-  
 
 
 
-l  
Symptoms 
Relieved   
8. 8620 Selvam   35/ M 
Epigastric 
pain, nausea, 
vomiting, 
abdominal 
distension.  
48 
BT 
 
 
 
AT 
10900 
 
 
 
10900
55 
 
 
 
55
35 
 
 
 
33
2 
 
 
 
2 
3 
 
 
 
3 
6 
 
 
 
6 
13 
 
 
 
14 
98 
 
 
 
100 
15 
 
 
 
16 
165 
 
 
 
170 
Nil 
 
 
 
Nil 
Nil 
 
 
 
Nil 
Few 
Epi.cells 
 
 
Few 
Epi.cells 
Gastritis  
 
 
 
Normal  
Symptoms 
Relieved   
9. 3594 Leela   29/ F 
Epigastric 
pain, heart 
burn, nausea, 
vomiting, 
abdominal 
distension.  
 
48 
BT 
 
 
 
AT 
10400 
 
 
 
10800
55 
 
 
 
53
35 
 
 
 
35
4 
 
 
 
3 
7 
 
 
 
5 
9 
 
 
 
8 
13 
 
 
 
14 
110 
 
 
 
126 
20 
 
 
 
18 
156 
 
 
 
160 
Nil 
 
 
 
Nil 
Nil 
 
 
 
Nil 
Few 
Epi.cells 
 
 
Few 
Epi.cells 
- 
 
 
 
- 
Moderate 
response   
10. 4534 Ramadoss  36/ M 
Epigastric 
pain, heart 
burn, 
regurgitation, 
nausea, 
vomiting.  
48 
BT 
 
 
 
AT 
9100 
 
 
 
9800 
61 
 
 
 
65
35 
 
 
 
33
4 
 
 
 
2 
11 
 
 
 
11
13 
 
 
 
12
14 
 
 
 
15 
100 
 
 
 
98 
15 
 
 
 
15 
160 
 
 
 
160 
Nil 
 
 
 
Nil 
Nil 
 
 
 
Nil 
Few 
Epi.cells 
 
 
Few 
Epi.cells 
- 
 
 
 
-  
Symptoms 
Relieved   
11. 6130 Leela 48/ F 
Epigastric 
pain, heart 
burn, nausea, 
vomiting, 
abdominal 
distension. 
  
48 
BT 
 
 
 
AT 
10400 
 
 
 
9800 
55 
 
 
 
53
33 
 
 
 
35
2 
 
 
 
3 
5 
 
 
 
4 
9 
 
 
 
8 
14 
 
 
 
15 
120 
 
 
 
130 
25 
 
 
 
26 
150 
 
 
 
160 
Nil 
 
 
 
Nil 
Nil 
 
 
 
Nil 
Few 
Epi.cells 
 
 
Few 
Epi.cells 
-  
 
 
 
- 
Moderate 
Response 
12. 8743 Chitra   30/ F 
Epigastric 
pain, heart 
burn  
regurgitation, 
nausea, 
vomiting. 
48 
BT 
 
 
 
AT 
8800 
 
 
 
9800 
54 
 
 
 
60
34 
 
 
 
30
8 
 
 
 
5 
3 
 
 
 
3 
6 
 
 
 
6 
9.5 
 
 
 
11 
105 
 
 
 
100 
18 
 
 
 
20 
177 
 
 
 
160 
Nil 
 
 
 
Nil 
Nil 
 
 
 
Nil 
Few 
Epi.cells 
 
 
Few 
Epi.cells 
Gastritis  
 
 
 
Normal  
Symptoms 
Relieved   
13. 1644 
Nandha 
Gopal   
25/ M 
Epigastric 
pain, nausea, 
vomiting, 
abdominal 
distension.  
48 
BT 
 
 
 
AT 
9800 
 
 
 
10400
60 
 
 
 
55
34 
 
 
 
33
6 
 
 
 
3 
5 
 
 
 
4 
10 
 
 
 
8 
11 
 
 
 
12 
82 
 
 
 
100 
18 
 
 
 
20 
145 
 
 
 
155 
Nil 
 
 
 
Nil 
Nil 
 
 
 
Nil 
Few 
Epi.cells 
 
 
Few 
Epi.cells 
Gastritis  
 
 
 
Normal  
Symptoms 
Relieved   
14. 1612 
Pranol 
kumar  
46/ M 
Epigastric 
pain, heart 
burn, nausea, 
vomiting, 
abdominal 
distension. 
 
 
48 
BT 
 
 
 
AT 
10700 
 
 
 
10800
51 
 
 
 
53
35 
 
 
 
33
2 
 
 
 
3 
2 
 
 
 
2 
5 
 
 
 
5 
12 
 
 
 
13 
120 
 
 
 
130 
30 
 
 
 
25 
150 
 
 
 
155 
Nil 
 
 
 
Nil 
Nil 
 
 
 
Nil 
Few 
Epi.cells 
 
 
Few 
Epi.cells 
Gastritis  
 
 
 
Normal  
Symptoms 
Relieved   
15. 2260 Elavarasan   46/ M 
Epigastric 
pain, heart 
pain, 
regurgitation, 
nausea, 
vomiting. 
 
48 
BT 
 
 
 
AT 
9500 
 
 
 
10800
50 
 
 
 
53
33 
 
 
 
33
8 
 
 
 
2 
5 
 
 
 
4 
9 
 
 
 
8 
11 
 
 
 
13 
84 
 
 
 
110 
19 
 
 
 
21 
173 
 
 
 
150 
Nil 
 
 
 
Nil 
Nil 
 
 
 
Nil 
Few 
Epi.cells 
 
 
Few 
Epi.cells 
Gastritis  
 
 
 
Normal  
Symptoms 
Relieved   
16. 4110 Franklin  47/ M 
Epigastric 
pain, heart 
burn, nausea, 
vomiting, 
abdominal 
distension. 
  
48 
BT 
 
 
 
AT 
10500 
 
 
 
10800
64 
 
 
 
55
31 
 
 
 
35
5 
 
 
 
5 
8 
 
 
 
5 
10 
 
 
 
8 
10.5 
 
 
 
13 
109 
 
 
 
110 
26 
 
 
 
25 
200 
 
 
 
150 
Nil 
 
 
 
Nil 
Nil 
 
 
 
Nil 
Few 
Epi.cells 
 
 
Few 
Epi.cells 
Gastritis  
 
 
 
Normal  
Symptoms 
Relieved   
17. 4446 
Meenachi 
Sundaram  
75/M 
Epigastric 
pain, nausea, 
vomiting.  
48 
BT 
 
 
 
AT 
10700 
 
 
 
10800
64 
 
 
 
53
31 
 
 
 
32
5 
 
 
 
3 
9 
 
 
 
5 
11 
 
 
 
9 
11 
 
 
 
13 
156 
 
 
 
110 
28 
 
 
 
24 
172 
 
 
 
155 
Nil 
 
 
 
Nil 
Nil 
 
 
 
Nil 
Few 
Epi.cells 
 
 
Few 
Epi.cells 
Gastritis  
 
 
 
Normal  
Symptoms 
Relieved   
18. 4422 Surendren  40/ M 
Epigastric 
pain, Heart 
burn, nausea, 
vomiting, 
abdominal 
distension.  
 
48 
BT 
 
 
 
AT 
9800 
 
 
 
10400
60 
 
 
 
55
35 
 
 
 
30
3 
 
 
 
2 
5 
 
 
 
4 
9 
 
 
 
8 
12 
 
 
 
13 
110 
 
 
 
1250 
30 
 
 
 
25 
150 
 
 
 
155 
Nil 
 
 
 
Nil 
Nil 
 
 
 
Nil 
Few 
Epi.cells 
 
 
Few 
Epi.cells 
- 
 
 
 
- 
Moderate 
response  
19. 5211 Sumathi  40/ F 
Epigastric 
pain, Heart 
burn, nausea, 
vomiting, 
abdominal 
distension.  
48 
BT 
 
 
 
AT 
10400 
 
 
 
10800
62 
 
 
 
60
33 
 
 
 
33
3 
 
 
 
4 
10 
 
 
 
8 
12 
 
 
 
10
10 
 
 
 
12 
118 
 
 
 
116 
24 
 
 
 
24 
170 
 
 
 
160 
Nil 
 
 
 
Nil 
Nil 
 
 
 
Nil 
Few 
Epi.cells 
 
 
Few 
Epi.cells 
- 
 
 
 
-  
Symptoms 
Relieved   
20. 7112 Tamilarasi 33/ F 
Epigastric 
pain, Heart 
burn, 
regurgitation, 
nausea, 
vomiting, 
abdominal 
distension.  
48 
BT 
 
 
 
AT 
10400 
 
 
 
10800
66 
 
 
 
55
28 
 
 
 
35
6 
 
 
 
3 
5 
 
 
 
4 
10 
 
 
 
8 
9.5 
 
 
 
13 
82 
 
 
 
100 
18 
 
 
 
17 
173 
 
 
 
165 
Nil 
 
 
 
Nil 
Nil 
 
 
 
Nil 
Few 
Epi.cells 
 
 
Few 
Epi.cells 
Gastritis  
 
 
 
Normal  
Symptoms 
Relieved   
21. 9140 Poornum  58/ F 
Epigastric 
pain,  
abdominal 
distension.  
48 
BT 
 
 
 
AT 
10000 
 
 
 
10400
67 
 
 
 
60
25 
 
 
 
35
5 
 
 
 
4 
3 
 
 
 
4 
6 
 
 
 
8 
9.5 
 
 
 
12 
120 
 
 
 
115 
15 
 
 
 
25 
170 
 
 
 
160 
Nil 
 
 
 
Nil 
Nil 
 
 
 
Nil 
Few 
Epi.cells 
 
 
Few 
Epi.cells 
-  
 
 
 
- 
Symptoms 
Relieved   
22. 9508 Malliga  51/ F 
Epigastric 
pain, 
regurgitation, 
nausea, 
vomiting, 
abdominal 
distension.  
48 
BT 
 
 
 
AT 
9800 
 
 
 
10400
60 
 
 
 
55
34 
 
 
 
33
6 
 
 
 
4 
9 
 
 
 
10
11 
 
 
 
12
9.5 
 
 
 
12 
126 
 
 
 
115 
29 
 
 
 
25 
168 
 
 
 
158 
Nil 
 
 
 
Nil 
Nil 
 
 
 
Nil 
Few 
Epi.cells 
 
 
Few 
Epi.cells 
-  
 
 
 
- 
Moderate 
response  
23. 6736 Vijaya  38/ F 
Epigastric 
pain, Heart 
burn, nausea, 
vomiting, 
abdominal 
distension. 
48 
BT 
 
 
 
AT 
9400 
 
 
 
10800
60 
 
 
 
55
34 
 
 
 
30
6 
 
 
 
3 
5 
 
 
 
4 
10 
 
 
 
8 
10.5 
 
 
 
13 
92 
 
 
 
98 
22 
 
 
 
20 
170 
 
 
 
150 
Nil 
 
 
 
Nil 
Nil 
 
 
 
Nil 
Few 
Epi.cells 
 
 
Few 
Epi.cells 
-  
 
 
 
- 
Symptoms 
Relieved   
24. 47 Abitha  32/F 
Epigastric 
pain, Heart 
burn, nausea, 
vomiting, 
abdominal 
distension.  
48 
BT 
 
 
 
AT 
10400 
 
 
 
10800
60 
 
 
 
60
33 
 
 
 
25
7 
 
 
 
4 
10 
 
 
 
8 
12 
 
 
 
10
10 
 
 
 
13 
98 
 
 
 
100 
18 
 
 
 
24 
167 
 
 
 
200 
Nil 
 
 
 
Nil 
Nil 
 
 
 
Nil 
Few 
Epi.cells 
 
 
Few 
Epi.cells 
-  
 
 
 
- 
Symptoms 
Relieved   
25. 403 Merry  33/ F 
Epigastric 
pain, nausea, 
vomiting, 
abdominal 
distension.  
 
48 
BT 
 
 
 
AT 
9700 
 
 
 
10400
59 
 
 
 
55
36 
 
 
 
34
5 
 
 
 
3 
6 
 
 
 
7 
12 
 
 
 
9 
10 
 
 
 
11 
98 
 
 
 
110 
18 
 
 
 
20 
170 
 
 
 
155 
Nil 
 
 
 
Nil 
Nil 
 
 
 
Nil 
Few 
Epi.cells 
 
 
Few 
Epi.cells 
-  
 
 
 
-  
Symptoms 
Relieved   
26. 625 Kathiresan  68/ M 
Epigastric 
pain, Heart 
burn, 
abdominal 
distension.  
48 
BT 
 
 
 
AT 
10200 
 
 
 
10800
76 
 
 
 
50
20 
 
 
 
32
1 
 
 
 
4 
4 
 
 
 
3 
6 
 
 
 
6 
12 
 
 
 
12 
120 
 
 
 
97 
18 
 
 
 
21 
170 
 
 
 
165 
Nil 
 
 
 
Nil 
Nil 
 
 
 
Nil 
Few 
Epi.cells 
 
 
Few 
Epi.cells 
-  
 
 
 
-l  
Moderate 
response  
27. 1112 Perumal  62/M 
 
Epigastric 
pain, Heart 
burn, nausea, 
vomiting, 
abdominal 
distension.  
 
48 
BT 
 
 
 
AT 
9400 
 
 
 
10800
57 
 
 
 
55
38 
 
 
 
33
5 
 
 
 
3 
4 
 
 
 
4 
8 
 
 
 
8 
11 
 
 
 
13 
90 
 
 
 
115 
25 
 
 
 
25 
177 
 
 
 
160 
Nil 
 
 
 
Nil 
Nil 
 
 
 
Nil 
Few 
Epi.cells 
 
 
Few 
Epi.cells 
-  
 
 
 
- 
Moderate 
response  
28 1151 Latha  34/F 
Epigastric 
pain, Heart 
burn, nausea, 
vomiting, 
abdominal 
distension. 
  
48 
BT 
 
 
 
AT 
10200 
 
 
 
10800
60 
 
 
 
55
32 
 
 
 
31
3 
 
 
 
4 
9 
 
 
 
6 
12 
 
 
 
9 
10.5 
 
 
 
13 
135 
 
 
 
112 
22 
 
 
 
24 
156 
 
 
 
165 
Nil 
 
 
 
Nil 
Nil 
 
 
 
Nil 
Few 
Epi.cells 
 
 
Few 
Epi.cells 
-  
 
 
 
- 
Symptoms 
Relieved   
29. 2255 Puruchotaman  41/M 
Epigastric 
pain, nausea, 
vomiting, 
abdominal 
distension.  
48 
BT 
 
 
 
AT 
9800 
 
 
 
10400
40 
 
 
 
54
32 
 
 
 
33
1 
 
 
 
2 
4 
 
 
 
3 
8 
 
 
 
6 
12 
 
 
 
13 
96 
 
 
 
98 
25 
 
 
 
22 
167 
 
 
 
150 
Nil 
 
 
 
Nil 
Nil 
 
 
 
Nil 
Few 
Epi.cells 
 
 
Few 
Epi.cells 
-  
 
 
 
- 
Symptoms 
Relieved   
30 2601 
Hema 
chandran 
55/M 
Epigastric 
pain, Heart 
burn, nausea, 
vomiting, 
abdominal 
distension.  
 
48 
BT 
 
 
 
AT 
10800 
 
 
 
8400 
64 
 
 
 
57
31 
 
 
 
34
5 
 
 
 
4 
5 
 
 
 
4 
10 
 
 
 
8 
12 
 
 
 
11 
120 
 
 
 
115 
29 
 
 
 
26 
214 
 
 
 
159 
Nil 
 
 
 
Nil 
Nil 
 
 
 
Nil 
Few 
pus.cells 
 
 
Few 
Epi.cells 
-  
 
 
 
- 
Symptoms 
Relieved   
31. 5041 
Krishna  
samy 
58/M 
Epigastric 
pain, Heart 
burn, nausea, 
vomiting, 
abdominal 
distension.  
 
48 
BT 
 
 
 
AT 
10000 
 
 
 
9800 
63 
 
 
 
57
31 
 
 
 
38
6 
 
 
 
5 
9 
 
 
 
11
11 
 
 
 
13
12 
 
 
 
11 
100 
 
 
 
112 
14 
 
 
 
27 
175 
 
 
 
200 
Nil 
 
 
 
Nil 
Nil 
 
 
 
Nil 
Few 
Epi.cells 
 
 
Few 
Epi.cells 
-  
 
 
 
- 
Symptoms 
Relieved   
32. 5971 Ponnammal  40/F 
Epigastric 
pain, Heart 
burn. 
48 
BT 
 
 
 
AT 
10400 
 
 
 
10800
62 
 
 
 
60
32 
 
 
 
30
6 
 
 
 
4 
5 
 
 
 
4 
10 
 
 
 
8 
10 
 
 
 
12 
112 
 
 
 
110 
22 
 
 
 
20 
183 
 
 
 
150 
Nil 
 
 
 
Nil 
Nil 
 
 
 
Nil 
Few 
Epi.cells 
 
 
Few 
Epi.cells 
-  
 
 
 
- 
Symptoms 
Relieved   
33. 5691 Balan  60/M 
Epigastric 
pain,  
nausea, 
vomiting.  
48 
BT 
 
 
 
AT 
8700 
 
 
 
10400
55 
 
 
 
54
35 
 
 
 
33
7 
 
 
 
4 
10 
 
 
 
10
12 
 
 
 
12
9 
 
 
 
10 
133 
 
 
 
120 
24 
 
 
 
25 
209 
 
 
 
180 
Nil 
 
 
 
Nil 
Nil 
 
 
 
Nil 
Few 
Epi.cells 
 
 
Few 
Epi.cells 
-  
 
 
 
-l  
Moderate 
response  
34. 6268 Sekar 53/M 
Epigastric 
pain, Heart 
burn, nausea, 
vomiting, 
abdominal 
distension.  
 
48 
BT 
 
 
 
AT 
10400 
 
 
 
10600
66 
 
 
 
62
30 
 
 
 
33
4 
 
 
 
3 
12 
 
 
 
10
14 
 
 
 
12
11.5 
 
 
 
13 
113 
 
 
 
115 
31 
 
 
 
25 
205 
 
 
 
200 
Nil 
 
 
 
Nil 
Nil 
 
 
 
Nil 
Few 
Epi.cells 
 
 
Few 
Epi.cells 
-  
 
 
 
- 
Symptoms 
Relieved   
35. 6321 Balaji 27/M 
Epigastric 
pain, nausea, 
vomiting, 
abdominal 
distension.  
48 
BT 
 
 
 
AT 
10000 
 
 
 
10100
60 
 
 
 
55
37 
 
 
 
33
4 
 
 
 
5 
8 
 
 
 
10
12 
 
 
 
14
14 
 
 
 
15 
118 
 
 
 
119 
18 
 
 
 
22 
118 
 
 
 
128 
Nil 
 
 
 
Nil 
Nil 
 
 
 
Nil 
Few 
Epi.cells 
 
 
Few 
Epi.cells 
-  
 
 
 
- 
Symptoms 
Relieved   
36. 7436 Kamala  33/F 
Epigastric 
pain, Heart 
burn, 
abdominal 
distension.  
48 
BT 
 
 
 
AT 
9700 
 
 
 
9900 
55 
 
 
 
53
32 
 
 
 
35
9 
 
 
 
4 
10 
 
 
 
10
12 
 
 
 
12
14 
 
 
 
13 
120 
 
 
 
115 
18 
 
 
 
25 
170 
 
 
 
165 
Nil 
 
 
 
Nil 
Nil 
 
 
 
Nil 
Few 
Epi.cells 
 
 
Few 
Epi.cells 
-  
 
 
 
- 
Symptoms 
Relieved   
37. 7960 
Dhana  
Lakshmi 
24/F 
Epigastric 
pain, Heart 
burn, nausea, 
vomiting, 
abdominal 
distension.  
48 
BT 
 
 
 
AT 
10600 
 
 
 
10800
55 
 
 
 
52
34 
 
 
 
32
6 
 
 
 
3 
4 
 
 
 
3 
8 
 
 
 
6 
14 
 
 
 
15 
75 
 
 
 
85 
21 
 
 
 
19 
155 
 
 
 
170 
Nil 
 
 
 
Nil 
Nil 
 
 
 
Nil 
Few 
Epi.cells 
 
 
Few 
Epi.cells 
-  
 
 
 
-l  
Moderate 
response  
38. 8434 Selvi  51/F 
Epigastric 
pain, Heart 
burn, nausea, 
vomiting, 
abdominal 
distension.  
48 
BT 
 
 
 
AT 
9800 
 
 
 
9600 
57 
 
 
 
57
34 
 
 
 
32
4 
 
 
 
4 
9 
 
 
 
8 
10 
 
 
 
10
10.5 
 
 
 
12 
84 
 
 
 
85 
18 
 
 
 
18 
161 
 
 
 
172 
Nil 
 
 
 
Nil 
Nil 
 
 
 
Nil 
Few 
Epi.cells 
 
 
Few 
Epi.cells 
-  
 
 
 
-l  
Symptoms 
Relieved   
39. 9859 Tamilarasi   39/F 
Epigastric 
pain, nausea, 
vomiting,  
48 
BT 
 
AT 
10400 
 
10600
51 
 
52
30 
 
35
2 
 
3 
4 
 
4 
8 
 
9 
12 
 
12.5
90 
 
94 
22 
 
25 
175 
 
180 
Nil 
 
Nil 
Nil 
 
Nil 
Few 
Epi.cells 
 
Few 
Epi.cells 
-  
 
 
 
- 
Symptoms 
Relieved   
40. 9857 Sujatha  35/F 
Epigastric 
pain, nausea, 
vomiting. 
48 
BT 
 
 
AT 
10900 
 
 
10100
55 
 
 
55
30 
 
 
30
4 
 
 
5 
5 
 
 
4 
10 
 
 
8 
15 
 
 
14 
115 
 
 
110 
15 
 
 
18 
165 
 
 
170 
Nil 
 
 
Nil 
Nil 
 
 
Nil 
Few 
Epi.cells 
 
Few 
Epi.cells  
-  
 
 
 
- 
Symptoms 
Relieved  
 
Hb – Haemoglobin,  Sug -  Sugar,  Serum Cho – Serum Cholesterol,   Alb – Albumin,   Dep – Deposits,  
Few Epi Cells – Few Epithelial Cells. 
S.No 
Op 
No Name/ Age/ Sex Complaints Days
 
 
BT
AT
Investigations  
 
 
Results 
Blood Serum  Urine  
 TC 
DC ESR 
Hb Urea Serum cholesterol Alb Sug Dep
P L E ½ hr 
1 
hr 
1. 5128 Jeganathan 60/M 
Polyuria 
Polydipsia 
Polyphagia 
Giddiness 
Fatigue 
48 
BT 
 
 
AT
10500
 
 
10800
55
 
 
53
35
 
 
34
2 
 
 
3
4 
 
 
4 
6 
 
 
8 
12 
 
 
12 
26 
 
 
25 
168 
 
 
158 
Nil 
 
 
Nil 
+ 
 
 
Nil 
Few
Epi 
Few
Epi 
Good 
2. 5317 Uma 60/F 
Polyuria 
Polydipsia 
Polyphagia 
Giddiness 
Fatigue 
 
48 
BT 
 
 
AT
10400
 
 
10700
60
 
 
58
30
 
 
32
3 
 
 
2
4 
 
 
4 
8 
 
 
6 
112 
 
 
115 
23 
 
 
22 
171 
 
 
160 
Nil 
 
 
Nil 
++ 
 
 
Nil 
Few
Epi 
Few
Epi 
Good 
3. 1171 Indhra  45/F 
Polyuria 
Polydipsia 
Polyphagia 
Fatigue 
Peripheral 
Neuritis 
48 
BT 
 
 
AT
10300
 
 
10350
54
 
 
53
32
 
 
33
2 
 
 
4
6 
 
 
4 
10 
 
 
8 
12 
 
 
13 
24 
 
 
22 
173 
 
 
155 
Nil 
 
 
Nil 
Nil 
 
 
Nil 
Few
Epi 
Few
Epi 
Good 
4. 1721 Sangeetha 53/F 
Polyuria 
Polydipsia 
Polyphagia 
Giddiness 
Fatigue 
50 
BT 
 
 
AT
10300
 
 
10400
56
 
 
50
30
 
 
29
2 
 
 
4
4 
 
 
3 
8 
 
 
6 
12 
 
 
13 
22 
 
 
19 
196 
 
 
170 
Nil 
 
 
Nil 
+ 
 
 
Nil 
Few
Epi 
Few
Epi 
Good 
5. 3795 Kamala  52/F 
Polyuria 
Polydipsia 
Polyphagia 
Giddiness 
 
48 
BT 
 
 
AT
10500
 
 
1700 
52
 
 
53
30
 
 
31
2 
 
 
3
4 
 
 
5 
7 
 
 
8 
12 
 
 
12 
23 
 
 
22 
181 
 
 
170 
Nil 
 
 
Nil 
++ 
 
 
Nil 
Few
Epi 
Few
Epi 
Good 
6. 4089 Malliga  50/F 
Polyuria 
Polydipsia 
Polyphagia 
Peripheral 
Neuritis 
 
48 
BT 
 
 
AT 
 
10300
 
 
10400
50
 
 
51
30
 
 
33
2 
 
 
4
2 
 
 
4 
4 
 
 
6 
12 
 
 
13 
27 
 
 
23 
178 
 
 
165 
Nil 
 
 
Nil 
+ 
 
 
Nil 
Few
Epi 
Few
Epi 
Moderate 
7. 4660 Bharath  52/M 
Polyuria 
Polydipsia 
Polyphagia 
Giddiness 
Peripheral 
Neuritis 
48 
BT 
 
 
AT
10200
 
 
1300 
50
 
 
49
30
 
 
32
2 
 
 
5
4 
 
 
2 
6 
 
 
4 
12 
 
 
14 
26 
 
 
23 
162 
 
 
152 
Nil 
 
 
Nil 
+ 
 
 
Nil 
Few
Epi 
Few
Epi 
Good 
8. 4527 Anna Poorani 46/F 
Polyuria 
Polydipsia 
Giddiness 
Fatigue 
Peripheral 
Neuritis 
48 
BT 
 
 
AT
10100
 
 
10300
52
 
 
55
30
 
 
31
2 
 
 
4
4 
 
 
2 
8 
 
 
8 
12 
 
 
14 
23 
 
 
22 
163 
 
 
159 
Nil 
 
 
Nil 
+ 
 
 
Nil 
Few
Epi 
Few
Epi 
Moderate 
9. 4621 Leelavathi  49/F 
Polyuria 
Polydipsia 
Polyphagia 
Giddiness 
Fatigue 
 
48 
BT 
 
 
AT
10500
 
 
10600
60
 
 
59
33
 
 
32
2 
 
 
3
4 
 
 
2 
6 
 
 
4 
13 
 
 
14 
27 
 
 
23 
169 
 
 
158 
Nil 
 
 
Nil 
+ 
 
 
Nil 
Few
Epi 
Few
Epi 
Good 
10. 9726 Rajamani 48/M 
Polyuria 
Polydipsia 
Peripheral 
Neuritis 
Polyphagia 
48 
BT 
 
 
AT
10400
 
 
10500
60
 
 
50
33
 
 
34
2 
 
 
4
4 
 
 
2 
8 
 
 
4 
12 
 
 
12 
26 
 
 
25 
160 
 
 
157 
Nil 
 
 
Nil 
Nil 
 
 
Nil 
Few
Epi 
Few
Epi 
Moderate 
11. 9734 Lalitha  50/F 
Polyuria 
Polydipsia 
Fatique 
Giddiness 
Polyphagia 
48 
BT 
 
 
AT
9800 
 
 
10300
60
 
 
59
33
 
 
34
2 
 
 
4
4 
 
 
2 
8 
 
 
4 
12 
 
 
12 
23 
 
 
22 
176 
 
 
160 
Nil 
 
 
Nil 
+ 
 
 
Nil 
Few
Epi 
Few
Epi 
Good 
12. 1620 Sujatha  34/F 
Polyuria 
Polydipsia 
Fatigue 
Peripheral 
Neuritis 
Giddiness 
Polyphagia 
48 
BT 
 
 
AT
10400
 
 
10500
60
 
 
59
34
 
 
33
6 
 
 
5
12
 
 
6 
20 
 
 
10 
10.5
 
 
12 
18 
 
 
17 
156 
 
 
150 
Nil 
 
 
Nil 
++ 
 
 
Nil 
Few
Epi 
Few
Epi 
Good 
13. 1572 Gandhimadhi 43/F 
Polyuria 
Polydipsia 
Fatigue 
Peripheral 
Neuritis 
Giddiness 
Polyphagia 
48 
Bt 
 
 
AT
9700 
 
 
10200
59
 
 
55
36
 
 
35
3 
 
 
3
5 
 
 
5 
9 
 
 
10 
10 
 
 
12 
18 
 
 
17 
170 
 
 
160 
Nil 
 
 
Nil 
Nil 
 
 
Nil 
Few
Epi 
Few
Epi 
Good 
14. 16584 Akli 45/F 
Polyuria 
Polydipsia 
Fatigue 
Peripheral 
Neuritis 
Giddiness 
Polyphagia 
48 
BT 
 
 
AT
10300
 
 
10400
59
 
 
58
35
 
 
33
2 
 
 
3
5 
 
 
5 
10 
 
 
8 
12 
 
 
13 
18 
 
 
17 
160 
 
 
150 
Nil 
 
 
Nil 
++ 
 
 
Nil 
Few
Epi 
Few
Epi 
Poor 
15. 5092 Syed Unksen 48/M 
Polyuria 
Polydipsia 
Fatigue 
Peripheral 
Neuritis 
Giddiness 
Polyphagia 
48 
BT 
 
 
AT
10200
 
 
10300
60
 
 
58
33
 
 
34
2 
 
 
3
5 
 
 
4 
10 
 
 
8 
12 
 
 
13 
27 
 
 
25 
200 
 
 
180 
Nil 
 
 
Nil 
Nil 
 
 
Nil 
Few
Epi 
Few
Epi 
Good 
16. 5956 Thangappan 47/M 
Polyuria 
Polydipsia 
Fatigue 
Peripheral 
Neuritis 
Giddiness 
Polyphagia 
48 
BT 
 
 
AT
9700 
 
 
10400
58
 
 
62
36
 
 
34
6 
 
 
4
11
 
 
10
20 
 
 
14 
11 
 
 
10 
21 
 
 
21 
189 
 
 
170 
Nil 
 
 
Nil 
Nil 
 
 
Nil 
Few
Epi 
Few
Epi 
Poor 
17. 169 Valliammai 67/F 
Polyuria 
Polydipsia 
Fatigue 
Peripheral 
Neuritis 
Giddiness 
Polyphagia 
48 
BT 
 
 
AT
8200 
 
 
9800 
60
 
 
59
33
 
 
30
2 
 
 
2
2 
 
 
2 
4 
 
 
4 
9 
 
 
11 
27 
 
 
25 
179 
 
 
172 
Nil 
 
 
Nil 
Nil 
 
 
Nil 
Few
Epi 
Few
Epi 
Good 
18. 4893 Nataraj 65/M 
Polyuria 
Polydipsia 
Fatigue 
Peripheral 
Neuritis 
Giddiness 
Polyphagia 
48 
BT 
 
 
AT
9200 
 
 
10300
59
 
 
55
35
 
 
34
6 
 
 
4
10
 
 
5 
18 
 
 
10 
11 
 
 
12 
28 
 
 
26 
200 
 
 
170 
Nil 
 
 
Nil 
++ 
 
 
Nil 
Few
Epi 
Few
Epi 
Moderate 
19. 8506 Selvarangam 66/M 
Polyuria 
Polydipsia 
Fatigue 
Peripheral 
Neuritis 
Giddiness 
Polyphagia 
48 
BT 
 
 
AT
9500 
 
 
10300
58
 
 
55
36
 
 
34
6 
 
 
4
4 
 
 
4 
8 
 
 
6 
11 
 
 
12 
33 
 
 
30 
220 
 
 
190 
Nil 
 
 
Nil 
Nil 
 
 
Nil 
Few
Epi 
Few
Epi 
Good 
20. 9935 Sumathi 36/F 
Polyuria 
Polydipsia 
Fatigue 
Peripheral 
Neuritis 
Giddiness 
Polyphagia 
48 
BT 
 
 
AT
9400 
 
 
10300
57
 
 
55
38
 
 
35
5 
 
 
3
5 
 
 
5 
11 
 
 
10 
10 
 
 
12 
18 
 
 
17 
170 
 
 
160 
Nil 
 
 
Nil 
Nil 
 
 
Nil 
Few
Epi 
Few
Epi 
Good 
21. 436 Sasikala 42/F 
Polyuria 
Polydipsia 
Fatigue 
Peripheral 
Neuritis 
Giddiness 
Polyphagia 
48 
BT 
 
 
AT
9500 
 
 
10300
57
 
 
55
37
 
 
34
7 
 
 
4
2 
 
 
4 
4 
 
 
6 
10 
 
 
11 
23 
 
 
22 
185 
 
 
170 
Nil 
 
 
Nil 
Nil 
 
 
Nil 
Few
Epi 
Few
Epi 
Good 
22. 781 Lakshman  62/M 
Polyuria 
Polydipsia 
Fatigue 
Peripheral 
Neuritis 
Giddiness 
Polyphagia 
48 
BT 
 
 
AT
9200 
 
 
9700 
57
 
 
59
38
 
 
35
5 
 
 
6
12
 
 
5 
20 
 
 
12 
10.5
 
 
11 
30 
 
 
29 
195 
 
 
192 
Nil 
 
 
Nil 
+ 
 
 
Nil 
Few
Epi 
Few
Epi 
Good 
23. 1954 Durai 70/M 
Polyuria 
Polydipsia 
Fatigue 
Peripheral 
Neuritis 
Giddiness 
Polyphagia 
48 
BT 
 
 
AT
10400
 
 
10500
57
 
 
55
38
 
 
33
 
5 
 
 
4 
 
5 
 
 
4 
10 
 
 
8 
10.5
 
 
11 
26 
 
 
24 
171 
 
 
160 
Nil 
 
 
Nil 
+ 
 
 
Nil 
Few
Epi 
Few
Epi 
Poor 
24. 2568 Ravi 45/M 
Polyuria 
Polydipsia 
Fatigue 
Peripheral 
Neuritis 
Giddiness 
Polyphagia 
48 
BT 
 
 
AT
10400
 
 
10500
55
 
 
53
38
 
 
35
5 
 
 
3
5 
 
 
2 
10 
 
 
4 
11 
 
 
12 
26 
 
 
23 
170 
 
 
150 
Nil 
 
 
Nil 
Nil 
 
 
Nil 
Few
Epi 
Few
Epi 
Good 
25. 2490 Karunanidhi  40/M 
Polyuria 
Polydipsia 
Fatigue 
Peripheral 
Neuritis 
Giddiness 
Polyphagia 
48 
BT 
 
 
AT
9800 
 
 
10400
57
 
 
53
38
 
 
33
2 
 
 
2
12
 
 
5 
14 
 
 
10 
11 
 
 
12 
25 
 
 
23 
170 
 
 
160 
Nil 
 
 
Nil 
Nil 
 
 
Nil 
Few
Epi 
Few
Epi 
Good 
26. 2581 Govindaswamy  65/M 
Polyuria 
Polydipsia 
Fatigue 
Peripheral 
Neuritis 
Giddiness 
Polyphagia 
48 
BT 
 
 
AT
10900
 
 
10900
55
 
 
50
24
 
 
23
6 
 
 
4
12
 
 
6 
18 
 
 
10 
11 
 
 
12 
28 
 
 
23 
210 
 
 
170 
Nil 
 
 
Nil 
+++
 
 
Nil 
Few
Epi 
Few
Epi 
Moderate 
27. 2541 Rajarathinam 70/M 
Polyuria 
Polydipsia 
Fatigue 
Peripheral 
Neuritis 
Giddiness 
Polyphagia 
48 
BT 
 
 
AT
10900
 
 
10900
70
 
 
55
24
 
 
30
6 
 
 
3
12
 
 
4 
20 
 
 
8 
11 
 
 
12 
28 
 
 
25 
210 
 
 
190 
Nil 
 
 
Nil 
Nil 
 
 
Nil 
Few
Epi 
Few
Epi 
Good 
28. 4079 Roobalingam 59/M 
Polyuria 
Polydipsia 
Fatigue 
Peripheral 
Neuritis 
Polyphagia 
48 
BT 
 
 
AT
10800
 
 
10900
55
 
 
54
29
 
 
30
4 
 
 
3
2 
 
 
4 
4 
 
 
6 
12 
 
 
13 
28 
 
 
24 
200 
 
 
180 
Nil 
 
 
Nil 
+ 
 
 
Nil 
Few
Epi 
Few
Epi 
Good 
29. 4594 Subbaiya  70/M 
Polyuria 
Polydipsia 
Fatigue 
Giddiness 
Polyphagia 
48 
BT 
 
 
AT
10800
 
 
10900
51
 
 
53
33
 
 
30
2 
 
 
3
4 
 
 
4 
8 
 
 
6 
12 
 
 
13 
21 
 
 
20 
155 
 
 
149 
Nil 
 
 
Nil 
Nil 
 
 
Nil 
Few
Epi 
Few
Epi 
Good 
30. 5279 Dhinakaran 47/M 
Polyuria 
Polydipsia 
Fatigue 
Giddiness 
Polyphagia 
48 
BT 
 
 
AT
9500 
 
 
10100
60
 
 
55
34
 
 
33
6 
 
 
4 
12
 
 
4 
20 
 
 
8 
11 
 
 
12 
25 
 
 
20 
150 
 
 
140 
Nil 
 
 
Nil 
Nil 
 
 
Nil 
Few
Epi 
Few
Epi 
Good 
31. 5295 Eswari 38/F 
Polyuria 
Polydipsia 
Fatigue 
Giddiness 
Polyphagia 
48 
BT 
 
 
AT
10300
 
 
10800
55
 
 
50
33
 
 
31
4 
 
 
3
4 
 
 
4 
8 
 
 
10 
12 
 
 
13 
22 
 
 
20 
150 
 
 
142 
Nil 
 
 
Nil 
Nil 
 
 
Nil 
Few
Epi 
Few
Epi 
 
Good 
32. 5315 Selvaraj Kumar 59/M 
Polyuria 
Polydipsia 
Fatigue 
Peripheral 
Neuritis 
Giddiness 
48 
BT 
 
 
AT
10200
 
 
10500
45
 
 
46
33
 
 
32
4 
 
 
2
4 
 
 
2 
10 
 
 
4 
11 
 
 
12 
23 
 
 
20 
150 
 
 
145 
Nil 
 
 
Nil 
Nil 
 
 
Nil 
Few
Epi 
Few
Epi 
Good 
33. 6007 Hemachandran 55/M 
Polyuria 
Polydipsia 
Fatigue 
Giddiness 
Polyphagia 
48 
BT 
 
 
AT
10800
 
 
10900
64
 
 
57
31
 
 
34
5 
 
 
9
5 
 
 
5 
9 
 
 
9 
12 
 
 
11 
29 
 
 
26 
214 
 
 
159 
Nil 
 
 
Nil 
Nil 
 
 
Nil 
Few
Epi 
Few
Epi 
Good 
34. 7284 Thomas  70/M 
Polyuria 
Polydipsia 
Fatigue 
Giddiness 
Polyphagia 
48 
BT 
 
 
AT
9500 
 
 
10300
54
 
 
50
35
 
 
32
7 
 
 
6
3 
 
 
4 
6 
 
 
10 
11 
 
 
12 
26 
 
 
20 
172 
 
 
160 
Nil 
 
 
Nil 
+ 
 
 
Nil 
Few
Epi 
Few
Epi 
Good 
35. 6729 Chandra 53/F 
Polyuria 
Polydipsia 
Fatigue 
Giddiness 
Polyphagia 
 
48 
BT 
 
 
AT
9700 
 
 
10200
65
 
 
55
34
 
 
30
4 
 
 
3
5 
 
 
4 
10 
 
 
10 
12 
 
 
13 
20 
 
 
20 
170 
 
 
160 
Nil 
 
 
Nil 
Nil 
 
 
Nil 
Few
Epi 
Few
Epi 
Good 
36. 9986 Ezhumalai 55/M 
Polyuria 
Polydipsia 
Fatigue 
Peripheral 
Neuritis 
Giddiness 
 
48 
BT 
 
 
AT
10100
 
 
10300
55
 
 
54
30
 
 
31
3 
 
 
2
5 
 
 
5 
10 
 
 
8 
12 
 
 
13 
22 
 
 
20 
153 
 
 
150 
Nil 
 
 
Nil 
Nil 
 
 
Nil 
Few
Epi 
Few
Epi 
Good 
37. 8488 Parimala  56/F 
Polyuria 
Polydipsia 
Fatigue 
Giddiness 
Polyphagia 
48 
BT 
 
 
AT
10800
 
 
10900
55
 
 
53
30
 
 
31
 
 
3 
 
 
2 
 
 
5 
 
 
4 
10 
 
 
8 
12 
 
 
13 
23 
 
 
22 
181 
 
 
170 
Nil 
 
 
Nil 
Nil 
 
 
Nil 
Few
Epi 
Few
Epi 
Good 
38. 8397 Ramaswamy 55/M 
Polyuria 
Polydipsia 
Fatique 
Peripheral 
Neuritis 
Polyphagia 
48 
BT 
 
 
AT
10700
 
 
10800
54
 
 
55
33
 
 
30
2 
 
 
3
5 
 
 
4 
10 
 
 
6 
12 
 
 
12 
24 
 
 
23 
181 
 
 
170 
Nil 
 
 
Nil 
Nil 
 
 
Nil 
Few
Epi 
Few
Epi 
Good 
39. 8333 
Lalitha 
54/F  
 
Polyuria 
Polydipsia 
Giddiness 
Polyphagia 
 
48 
BT 
 
 
AT
10800
 
 
10900
55
 
 
52
30
 
 
32
4 
 
 
3
4 
 
 
4 
8 
 
 
10 
11 
 
 
13 
23 
 
 
20 
165 
 
 
155 
Nil 
 
 
Nil 
+ 
 
 
Nil 
Few
Epi 
Few
Epi 
Poor 
40. 8399 Ramaswamy 56/M 
Polyuria 
Polydipsia 
Giddiness 
Polyphagia 
48 
BT 
 
 
AT
9800 
 
 
10300
50
 
 
55
32
 
 
33
3 
 
 
2
4 
 
 
4 
10 
 
 
6 
12 
 
 
12 
22 
 
 
20 
173 
 
 
160 
Nil 
 
 
Nil 
Nil 
 
 
Nil 
Few
Epi 
Few
Epi 
Poor 
 
Hb – Haemoglobin, Sug – Sugar, Serum Cho – Serum Cholesterol, Alb-Albumin, Dep – Deposits, Few epi – Few epithelial cells.  
 
 
 
 
 
 
